Company index

288 companies found. = FIB member
Company	Contact information	Activities
4Pharma Ltd Lemminkäisenkatu 1, FI-20520 Turku, Finland Web site: www.4pharma.com Founded: 2002 Personnel: 15 (2004)	Marko Suojanen, Executive Vice President Phone: +358 44 029 7796 Fax: +358 2 283 5701 marko.suojanen at 4pharma.com Jari Turunen, Vice President, Technology Phone: +358 44 029 7783 Fax: +358 2 283 5701 jari.turunen at 4pharma.com	R&D activities: Local, world-class services in statistics, data management, data warehousing and medical writing. A wide variety of expertise in information technology, international regulatory affairs and pharmaceutical R&D overall. Categories of activity: Biotech support company; R&D service; Other service;
AB Enzymes Oy PO Box 26, FIN-05201 Rajamäki, Finland Web site: www.abenzymes.com Founded: 1997 Turnover: EUR 2,2 million (2004) Personnel: 14 (2004)	Pentti Ojapalo, Textile Group Manager Phone: +358 9 2902 2515 Fax: +358 9 2902 2550 pentti.ojapalo at abenzymes.fi	R&D activities: Development of technical enzyme applications. Core technologies: Technical enzymes for use in following industrial areas of application: detergent, textile, pulp and paper, animal feed. Categories of activity: Biotech company; Production; R&D; Enzymes;
Abacus Diagnostica Oy Ltd Tykistökatu 4 D, FI-20520 Turku, Finland Web site: www.abacusdiagnostica.com Founded: 2004	Tom Palenius, Managing Director Phone: +358 (0)20 7188 382 Fax: +358 (0)20 7188 381 tom.palenius at abacusdiagnostica.com	Production (and other) activities: Abacus Diagnostica Ltd is specialized in modern DNA testing technologies involving closed-tube detection of sensitive time-resolved fluorometric labels. The main product of Abacus Diagnostica is a proprietary, fully automated testing platform GenomEraTM that makes it possible to perform sophisticated DNA tests even outside a specialized laboratory environment. R&D activities: Rapid and simple DNA test systems for applications in medical and industrial diagnostics Core technologies: Closed-tube detection, Time-resolved fluorometry, GenomEra™ Tb and Eu labels, Competitive hybridization, End-point detection PCR Categories of activity: Biotech company; Production; R&D; Supplier; Diagnostics and devices; Environment; Research reagents;
Abcell Oy PO Box 62, FI-33101 Tampere, Finland Web site: www.abcell.fi Founded: 1990	Terho Eloranta, Managing Director Phone: Fax: +358 3 265 6213 abcell at kolumbus.fi	Production (and other) activities: Manufacturer of the unique AB-MAX Plasma Cell Growth supporters keeping antibody-producing B lymphocytes alive and rescuing dying hybridomas. Custom-tailored production of hybridoma cell lines, monoclonal and polyclonal antibodies, antisera and hen antibodies. Distributor services of IVD and research instruments, reagents and materials. Categories of activity: Biotech company; Production; Other service; Supplier; Diagnostics and devices; Research reagents;
Aboatox Oy Savikuja 2, FI-21250 MASKU, FINLAND Web site: www.aboatox.com Founded: 2001 Personnel: 1 (2009)	Juha Lappalainen, PhD, Managing Director Phone: +358 2 2410 244 Fax: +358 2 2410 244 juha.lappalainen at aboatox.com	Production (and other) activities: Production of toxicitymonitoring tests based on photobacterium Vibrio fischeri and Genetically Engineered Heavy Metal Biotests. Sales of luminometers and chemicals for luminescence analysis (ATP, reporter gene). Hygiene monitoring kits and instruments. Microscale environmental toxicity tests based on maintenance free Microbiotests. R&D activities: Improved use and new applications of luminescent bacteria. Kinetic measurement with photobacteria. Core technologies: Luminometry. Categories of activity: Biotech company; Production; R&D; Food and feed; Environment;
Afore Oy		Categories of activity:
Agropolis Oy		Categories of activity:
Ailab Solutions Oy Eteläinen Makasiinikatu 4, FIN-00130 Helsinki, Finland Web site: www.ailabsolutions.com Founded: 2000 Personnel: 6	Ari Aalto, CEO Phone: +358 400 801166 Fax: +358 9 6852030 ari.aalto at ailabsolutions.com Dr Tommi Rakshit, Business Development Phone: +358 40 585 6185 Fax: +358 9 685 2030 tommi.rakshit at ailabsolutions.com	Production (and other) activities: Our intelligent algorithms solve complex optimization, prediction and classification problems. They can handle hundreds of parameters and massive databases. The applications range from predicting molecule activity to modelling metabolic fluxes. R&D activities: We have more than ten joint R&D project with companies and university groups. The projects result new intelligent software tools for scientists and patentable scientific discoveries. Core technologies: All intelligent computational technologies including genetic algorithms, neural networks and support vector machines. Categories of activity: Biotech company; Bioinformatics;
AKELA Pharma Inc.		Categories of activity:
Akela Pharma Oy PO Box 980, FIN-20101 Turku, Finland Web site: www.labinc.fi Personnel: 42 (2004)	Bastiaan J. de Leeuw, Vice President, Business Development and Strategy Phone: +44 79 4135 6562 Fax: +358 2 333 3444 deleeuwb at akelapharma.com	Production (and other) activities: Production Rapid scaling-up of the manufacturing processes during the clinical phases of development.Production unit is part of 12,000 square metre facility. R&D activities: Expertise in carrier based dry powder formulation technologies including wet suspension technology with ultrasound processing produces highly homogeneous and physically stable powder formulations. Core technologies: LAB Pharma Oy offers an integrated product development partnership. Technology platform comprises patended powder formulations, approved TAIFUN inhaler and customised manufacturing technologies. Categories of activity: Biotech company; Production; R&D; Drug discovery; Diagnostics and devices;
Algol Pharma Oy Karapellontie 6, FI-02611 ESPOO, FINLAND Web site: www.algolpharma.com Founded: 1894 Turnover: EUR 46 million (2009) Personnel: 120 (2009)	Jarmo Niiranen, Manager, Business Development, Sales and Marketing Phone: +358408699332 Fax: jarmo.niiranen at algol.fi	Production (and other) activities: We are looking for new co-operation partners with prescription (Rx) medicines. Sales and marketing co-operation in the Nordic and Baltic countries (7 -Country Concept). R&D activities: We are actively looking for long term co-operation partners with pharmaceutical original manufacturers globally. Our expertise areas are sales and marketing and all pharmaceutical services. We would like to introduce our company and I hope we can arrange meeting with you if you are looking for high quality and trustworth business partner in Nordic and Baltic countries. This is a network of seven countries included. Core technologies: Our clients/partners are original manufacturers of Rx-pharmaceuticals from all over the world. Categories of activity: Biotech support company; Other service;
Alimetrics Ltd Web site: www.alimetrics.net		Categories of activity:
Alkomohr Biotech Oy Ltd Lehtotie 8, FIN-00630 Helsinki, Finland Founded: 1995 Personnel: 3	Dr Matti Korhola, Managing Director Phone: +358 50 562 6903 Fax: +358 9 728 3937 matti.korhola at yeast.pp.fi	R&D activities: Research, product and process development on industrial enzymes and yeasts. Core technologies: Baker's, brewer's, distiller's, sour dough, and wine yeast strain improvement by classical genetic breeding and by genetic engineering. Proprietary enzyme application technology. Categories of activity: Biotech support company; Other service; Enzymes;
Ani Biotech Oy Tiilitie 3, FI-01720 Vantaa, Finland Web site: aimo.niskanen@anibiotech.fi Founded: 1987 Turnover: EUR 1,5 million (2009) Personnel: 18 (2009)	Niskanen Aimo, CEO Phone: 020 1557512 Fax: 020 1557517	Production (and other) activities: Manufacturing lateral flow rapid tests for infectious diseases, cardiac markers, gastroenterology tests and fertility tests. ELISA tests for infectious diseases, research kits for Interleucins (Orgenium business Unit) R&D activities: Developing new applications for main activity areas. Core technologies: Lateral Flow Technology, Multicannel technology and Dry dot agglutination technology, ELISA Categories of activity: Biotech company; Supplier; Diagnostics and devices; Research reagents;
Ani Labsystems Oy Ltd Tiilitie 3, FI-01720 Vantaa, Finland Web site: www.anilabsystems.com Founded: 2002 Turnover: EUR 3 million (2005) Personnel: 28 (2005)	Ilari Tuominen, Marketing Manager Phone: +358 40 518 6515 Fax: +358 20 155 7521 ilari.tuominen at anilabsystems.com Aimo Niskanen, Managing Director Phone: +358 400 454 020 Fax: +358 20 155 7521 aimo.niskanen at anibiotech.fi	Production (and other) activities: Diagnostic EIA kits and reagents for use in clinical and research laboratories. Main areas of interest: infectious diseases, neonatal screening and OEM manufacturing. Latest product launches in 2009: Neonatal screening tests for G6PD, 17-OHP and Galactosemia R&D activities: New generation EIA kits for respiratory infections, other infectious diseases, gastrology problems, hormone detection, blood screening and neonatal screening. Core technologies: EIA, FEIA, MIF. Categories of activity: Biotech company; Production; R&D; R&D service; Other service; Supplier; Diagnostics and devices; Biomaterials; Research reagents;
ArboNova Oy Ab		Categories of activity:
ArcDia Group - Arctic Diagnostics Oy and ArcDia International Oy Ltd. Tykistökatu 6, 20521 Turku, PL51 Web site: www.arcdia.com Founded: 1993 Turnover: EUR 0,5 million (2009) Personnel: 10 (2009)	Erkki Soini, CEO Phone: +358-400-520643 Fax: 02-4544159 erkki.soini at arcdia.com	Production (and other) activities: technology R&D and licensing R&D activities: in vitro diagnostics Core technologies: Two photon fluorescence excitation "TPX" Categories of activity: Biotech company; Production; R&D; Diagnostics and devices;
Ark Therapeutics Oy Microkatu 1 S, FI-70210 Kuopio, Finland Web site: www.arktherapeutics.com Founded: 1993 Turnover: EUR 9 million (2008) Personnel: 100 (2008)	Timo Ristola, Managing Director Phone: +358 17 240 879 Fax: +358 17 240 876 timo.ristola at arktherapeutics.com Matti Lähde, Production Director Phone: +358 17 240 873 Fax: +358 17 240 876 matti.lahde at arktherapeutics.com	Production (and other) activities: ARK offers proven expertise in the chemistry and manufacturing control (CMC) and development of biologicals, based on the common technical document (CTD) submission of Cerepro to EMEA in 2005/2008. ARK has the approved/registered facilities and quality systems to meet IMPD and commercial needs within Europe, for terminally filtered live viral products meeting BSL2 requirements. ARK has the capability to provide complete packages from research through development to commercial product fulfilling cGMP requirements R&D activities: ARK’s gene-based medicine research has provided numerous challenges to the GMP manufacturing development group, including analytical development and process validation. Core technologies: ARK has GMP clean rooms and development suites to allow product and process development from adherent into suspension cell processes. ARK will provide project documentation to meet GMP requirements for complete packages, and can offer full regulatory expertise in Europe and the USA ARK is able to offer expertise in biologics manufacture - from proof of concept to commercial manufacture, to other organisations. These may range from university start-ups to major pharma needing specialist filling of live BSL2 type product. Categories of activity: Biotech company; Production; R&D; R&D service; Drug discovery;
Aromtech Ltd Veturitallintie 1, FIN-95410 Kiviranta/Tornio, Finland Web site: www.aromtech.com Founded: 1991 Turnover: EUR 2 million (2006) Personnel: 13 (2006)	Dr Vesa-Pekka Judin, Managing Director Phone: +358 40 742 9639 Fax: +358 207 789 029 vesa-pekka.judin at aromtech.com Mr Veli-Markku Korteniemi, Chairman of the Board Phone: +358 400 392 494 Fax: +358 207 789 028 veli-markku.korteniemi at aromtech.com	Production (and other) activities: Marketing and manufacture of food supplements, as well as ingredients for cosmetics and functional foods R&D activities: Development of natural active ingredients for nutrition and cosmetics. Core technologies: Supercritical CO2 extraction Sea buckthorn: abundance, chemistry, processing, clinical trials/physiological effects Sourcing of highly functional natural ingredients of northern origin Categories of activity: Biotech support company; Production; R&D; Food and feed;
Astra Zeneca Oy		Categories of activity:
Atrotech Oy		Categories of activity:
Auratum Group		Categories of activity:
Avenly Oy Pohjanpellontie 16 D, FI-00780 Helsinki, Finland Web site: www.avenly.fi Founded: 1998 Personnel: <1 (2006)	Hannu Salovaara, Chairman of Board Phone: +358 400 417792 Fax: hannu.salovaara at avenly.fi	Production (and other) activities: Avenly Oy (Ltd.) studies and develops traditional foods processes to meet todays needs. The company has licensed out technology for an oat bran based alternative to dairy or soy yogurts. A commercially successful product has been on the market in Finland for several years. In the process, fermentation occurs, using probiotic bacteria. The substrate is high in functional oat beta-glucan. Both components, the probiotic bacteria and the soluble oat fibre provide health claim potential. Core technologies: Oat bran, fermentation. Categories of activity: Biotech support company; R&D; Other service; Food and feed;
B.Braun Medical Oy		Categories of activity:
Bayer Oy Bayer CropScience Suomalaistentie 7, FI-02270 Espoo, Finland Web site: www.bayercropscience.com Personnel: 1		Production (and other) activities: Markets crop protection products. Categories of activity: Biotech support company; Supplier; Agro;
Bayer Schering Pharma Oy PO Box 415, FIN-20101 Turku, Finland Founded: 1946 Personnel: 965	Hanna Räsänen, Technology Manager, Business Development Phone: +358 2 333 2413 Fax: +358 2 333 2650 hanna.rasanen at bayer.fi	Production (and other) activities: Production Production of polymer based implants and IUS (intra uterine systems) and production of traditional pharmaceuticals. R&D activities: Develops polymer based drug delivery systems and polymers controlling the release rate. Categories of activity: Biotech company; Production; R&D; Drug discovery;
BBS Bioactive Bone Substitutes Oy		Categories of activity:
BCB Medical Ltd.		Categories of activity:
BD Biosciences		Categories of activity:
Berggren Oy Ab		Categories of activity:
Bio Fund Management Oy Ltd PO Box 164, FI-00101 Helsinki, Finland Web site: www.biofund.fi Founded: 1997 Personnel: 11 (2007)	Morten Bro Nielsen, Managing Partner Phone: +45 2964 7727 Fax: +358 9 251 44 620 morten.bro.nielsen at biofund.dk	Production (and other) activities: Bio Fund Management Oy Ltd is one of the leading European venture capital management companies investing solely in life sciences. The main sectors include pharmaceuticals and therapies, medical technologies (medtech), cleantech and nutrition. BioFund's investment focus is exclusively on minority equity interests. BioFund makes investments solely in unlisted growth companies. In addition to early stage investments BioFund may also invest in expansion capital, turn-around and restructuring as well as MBO's and MBIs. BioFund is headquartered in Helsinki, Finland and maintains an office in Turku and in Copenhagen, Denmark. BioFund's ventures are concentrated in Europe, particularly in the Nordic countries. Categories of activity: Biotech support company;
Bio-Rad Laboratories Inc.		Categories of activity:
Biocelex Oy Lemminkäisenkatu 5 C, FI-20520 Turku, Finland Web site: www.biocelex.com Founded: 2007 Turnover: EUR <1 M€ million (2008) Personnel: 3 (2007)	Kai Lahtonen, President & CEO Phone: +358 50 689 48 Fax: +358 2 4788 488 kai.lahtonen at biocelex.com	Production (and other) activities: Biocelex Ltd is a privately-held international innovation and business development company offering services for the Life Sciences field. We focus on business and technology areas related to drug discovery & development, diagnostics, biomaterials, functional foods and life science services. Geographically we operate in Scandinavia and the Baltic Sea region, with a particular focus on Finland. In terms of Innovation Development, Biocelex adapts and applies the world famous and proven process of one of its co-owners, Karolinska Institutet Holding AB. We evaluate, consult and develop promising innovation to start-ups with a possibility for early-stage funding from Karolinska Development AB fund. Biocelex Ltd offers Business Development services for a broad range of Life Science companies. For growth phase companies, our experienced team can help you with e.g. strategy and business planning, product development and market entry. For established companies looking for new openings or additions to their product portfolio, we offer e.g. scouting services, due diligence or technical assessments and reports on the local operating environment. Categories of activity: Biotech support company; Other service;
BioChance Oy Laivurinrinne 2 A 6, FIN-00120 Helsinki, Finland Founded: 1998	Marja-Liisa Huhtala, Managing Director Phone: +358 9 68427900 and Fax: +358 9 6842 7901 marja-liisa.huhtala at kolumbus.fi	Production (and other) activities: Develops immunoassay technology and syntehtic peptide and recombinant antigens for infectious diseases serology. Categories of activity: Biotech company; R&D; Diagnostics and devices;
BIOCID Oy Ltd Teknobulevardi 3-5, PO Box 35, FI-01531 Vantaa Web site: www.biocid.com Founded: 2001 Turnover: EUR < 1 million Personnel: 5		Production (and other) activities: Oy BIOCID Ltd - advanced food hygiene technologies that offer an integrated service concept for optimizing production hygiene and improving operational quality in any food industry enterprise. Core technologies: BIOCID is not a traditional company in the biotechnology (microbiology and hygiene management) or electronics (electronic equipment and process control) sector, but rather represents an innovative combination of the two.BIOCID carries out design and production of electronic UVC irradiators, integrates systems, and supplies activated oxygen generators as well as control measuring and sensor technology. Categories of activity: Biotech company; Production; Other service; Diagnostics and devices; Food and feed;
BioCis Pharma Oy Pharmacity, Itäinen Pitkäkatu 4B, FI-20520 Turku, Finland Web site: www.biocis.com Founded: 2003 Personnel: 5 (2009)	Dr Lasse Leino, CEO Phone: +358 40 8494 694 Fax: +358 2 4788 371 lasse.leino at biocis.com Dr Jarmo Laihia, R&D Director Phone: +358 2 478 8378 Fax: +3582 478 8371 jarmo.laihia at biocis.com	R&D activities: Development of new drugs for inflammatory and cancer diseases. Core technologies: Drug development, protodynamic therapy, cis-urocanic acid based therapeutics. Categories of activity: Biotech company; R&D;
BioCity Turku		Categories of activity:
Bioclin Oy		Categories of activity:
Biocomputing Platforms Ltd Tekniikantie 14, FI-02150 Espoo, Finland Web site: www.bcplatforms.com Founded: 1997	Anita Eliasson, COO Phone: +358 9 2517 7340 Fax: +358 10 296 1288	Production (and other) activities: Marketing and development of data management solutions for genetic studies. Categories of activity: R&D service; Bioinformatics;
Biodeus Oy Lemminkäisenkatu 5C, FIN-20520 Turku, Finland Web site: www.biodeus.com Founded: 2000 Personnel: 5	Jan Parkki Phone: +358 400 536 835 Fax: +358 4 211 00 44 jan.parkki at biodeus.com	R&D activities: Biodeus develops new technology for protein purification. Categories of activity: Biotech company; R&D;
BioExpand Oy C/O Ovil Oy Korsintie 12, 01450 Vantaa Web site: www.bioexpand.fr Founded: 2005 Personnel: 1	Claude Lubicki, CEO Phone: +33 6 08 152652 Fax: claude.lubicki at bioexpand.fr	Production (and other) activities: BioExpand is an international Life Sciences Marketing and Business Development Consultancy. BioExpand particular focus is on offering services to Biotech / Pharmaceutical SMEs and BioClusters. BioExpand develops close cooperation with Private Equity and venture Capital firms as expert in its field Core technologies: Consulting Services Categories of activity: Biotech support company; Other service;
Biofellows Oy Koetilantie 1 C 18, FI-00790 Helsinki, Finland Web site: www.biofellows.com Founded: 1998 Turnover: EUR 2,5 million (2009) Personnel: 8 (2009)	Mr Veli-Pekka Karvinen, Managing Director Phone: +358 9 755 2550 Fax: +358 9 7552 5555 veli-pekka.karvinen at biofellows.com	Production (and other) activities: Distribution of molecular biology reagents and laboratory instruments. Categories of activity: Biotech support company; Supplier; Drug discovery; Diagnostics and devices; Enzymes; Research reagents;
Bioferme Oy Rauvolantie 64, FI-20760 Piispanristi, Finland Web site: www.bioferme.fi Founded: 1977 Turnover: EUR 2 million Personnel: 11	Merja Scharlin, Managing Director Phone: + 358 2 276 2600 Fax: + 358 2 276 2621 merja.scharlin at bioferme.fi Reetta Myllymäki, Marketing Assistant Phone: + 358 2 276 2600 Fax: + 358 2 276 2621 reetta.myllymaki at bioferme.fi	Production (and other) activities: Production Bioferme Oy manufactures Yosa and Yosa Plus oat products, fermented vegatable products and fruit/berry juices. Categories of activity: Biotech company; Production; Food and feed;
Biofile Ltd PO Box 450, FI-20101 Turku, Finland Web site: www.biofilediagnostics.com Founded: 1995	Vesa Kleimola, CEO Phone: + 358 2 481 81 00 Fax: + 358 2 481 81 01 vesa.kleimola at biofilediagnostics.com	Production (and other) activities: Biofile is a privately held Finnish company specialising in autoimmune disease and infectious disease diagnostics. The Company employs at the moment group of highly skilled and motivated professionals who develop and manufacture very sensitive and specific diagnostic test kits for gastroenterology autoimmune and infectious diseases. Biofile’s diagnostics products provide accuracy, simplicity and enable early disease diagnosis and treatment. All of Biofile's diagnostics products are used in procedures performed in vitro (outside the body) and enhance patient well being. The current product portfolio of Biofile, based on well-known ELISA/IFA technologies, consists of a panel of six diagnostic kits for celiac disease, kit for helicobacter pylori testing and two kits for diagnosing Crohn's disease. Additionally the Company focuses also to the importing of certain autoimmune diagnostic kits to the Local market and surraounding markets, private labels some supporting diagnostic kits and runs a specialist clinical service laboratory. Clinical Laboratory helps the Company to keep in touch with customers and their needs today and in the future. The Company has a strong background in research. Through its own personnel and scientific network Biofile has the technical expertise to enable research and product development efforts, in addition to celiac disease, in other autoimmune diseases as Crohn's disease, Colitis Ulcerosa and in infectious diseases as Helicobacter. Categories of activity: Biotech company; Production; Supplier; Diagnostics and devices;
Biohit Oyj Laippatie 1, FI-00880 Helsinki, Finland Web site: www.biohit.com Founded: 1988 Turnover: EUR 26,3 million (2003) Personnel: 298 (2003)	Osmo Suovaniemi, President & CEO Phone: +358 9 773 861 Fax: +358 9 773 86 205 osmo.suovaniemi at biohit.com	Production (and other) activities: Liquid handling: Electronic and mechanical pipettors, disposable pipettor tips, maintenance, calibration and training services. Diagnostics: Test panel (GastroPanel) for diagnosing Helicobacter pylori infection and atrophic gastritis as well as for screening the risk of gastric cancer, peptic ulcer, the reflux disease, and its complication, Barrett's oesophagus, from a blood sample. In addition, tests for the detection of lactose intolerance and systemic lupus erythematosus (SLE). Instruments: microplate readers, washers and related software, which support the performance and analysis of the results of the diagnostic tests. R&D activities: Liquid handling, diagnostics. Core technologies: Liquid handling, diagnostics, instruments, systems composed of the said product groups. Categories of activity: Biotech company; Production; Diagnostics and devices;
Bioka Oy Sokeritehtaantie 20, FI-02460 Kantvik, Finland Web site: www.bioka.fi Founded: 1992	Paavo Lehtonen, Managing Director Phone: +358 9 2230 2350 Fax: +358 9 2230 2350 paavo.lehtonen at kolumbus.fi	Production (and other) activities: Production Develops and manufactures enzyme based oxygen absorbers to be used in the packaging of food and pharmaceutical products. Core technologies: Oxygen absorbers Categories of activity: Biotech company;
Biomarket Oy Itäinen Pitkäkatu 4B, FI-20520 Turku, Finland Web site: www.biomarket.fi Founded: 2004 Personnel: 4 (2006)	Kari Kurki, Managing Director Phone: +358 400 523 213 Fax: +358 2 478 8681 kari.kurki at biomarket.fi Arja Mannila, Margeting Manager Phone: +358 50 3633 969 Fax: +358 2 478 8681 arja.mannila at biomarket.fi	Production (and other) activities: BioMarket Oy is a growing producer and distributor of diagnostic and molecular biology products for research groups, diagnostics industry and clinical laboratories. BioMarket Oy offers more than 100 products in the field of infectious diseases, monoclonal antibodies, antigens,cardiac markers and CARD-i-KIT immunochromatographic IVD tests, extracellular matrix, integrin, endocrinology and molecular biology products including modifying enzymes and PCR. reagents. Categories of activity: Biotech company; Other service; Supplier; Diagnostics and devices; Enzymes; Research reagents;
Biomedicum Genomics Oy Haartmaninkatu 8, FI 00290 Helsinki, Finland Web site: www.biomedicumgenomics.fi Founded: 2007 Personnel: 5 (2008)	Dr. Outi Monni, Director Phone: +358 40 763 9302 Fax: outi.monni at helsinki.fi Anne Mäkelä, Project Manager Phone: +358 9 191 256 31 Fax: anne.makela at helsinki.fi	Production (and other) activities: BIOMEDICUM GENOMICS (BMGen) is a new functional genomics service provider operating at Biomedicum Helsinki. BMGen promotes nationwide biotechnology development by providing academic and industrial clients access to many functional genomics technologies and services. BMGen offers variety of biochip services for genome-wide expression, copy number profiling, miRNA expression, DNA-protein interaction (ChIP-on-chip) including e.g. RNA/DNA extraction and RNA quality assessment. For gene silencing and ectopic expression purposes, we offer high-titer shRNA or ORF lentiviruses targeting genes of interest. We also offer customized services e.g. preparation of gain or loss-of-function cell lines. In addition, we provide access to wide array of computational data analyses. BMGen also offers partnering deals for clients interested in customized integration of several technologies. Core technologies: Lentivirus mediated RNAi and biochip technologies. Categories of activity: Biotech company; Production; R&D; Other service; Biomaterials;
Biomolecular Tools Finland Ltd.		Categories of activity:
BioNavis Oy Biokatu 6, FI-33520 Tampere, Finland Web site: www.bionavis.com Founded: 2006		Categories of activity:
Bioprojects Consulting Services Ltd. Vähäntorpankuja 7, FI-02180 Espoo	Lauri Jalkanen, Director Phone: +358-40-9030084 Fax: laurijalkanen(at)dlc.fi	Production (and other) activities: Consulting services: Business development of Life science fields. Assisting new (bio)technology based SMEs in focusing their strategies. Evaluation of new projects. Technology strategies. Market surveys. Business plans. Finding the necessary international business skills. Categories of activity: Other service;
Bioretec Oy Hermiankatu 22, Modulight Building, PO Box 135, FI-33721 Tampere, Finland Web site: www.bioretec.com Founded: 1998 Personnel: 29 (2009)	Pertti Viitanen, Chief Exectuive Officer Phone: +358 20 778 9500 Fax: +358 3 317 0225 pertti viitanen at bioretec.com Phone: Fax:	Production (and other) activities: Develops and manufactures new and innovative bioabsorbable devices for various fields of surgery in global markets. R&D activities: Development of novel bioabsorbable, bioactive or drug-releasing devices. Categories of activity: Biotech company; Production; R&D; Biomaterials;
BioSilta Oy PL 4300, 90014 Oulun yliopisto Web site: www.biosilta.com Founded: 2007 Personnel: 2009 (7)	Maria Ruottinen, Production manager Phone: +358-44 557 1862 Fax: maria.ruottinen at biosilta.com Russell Golson, CEO Phone: 08-553 2361 Fax: russell.golson at biosilta.com	Production (and other) activities: Production of fed-batch cultivation media for E.coli. EnBase is a time-saving cell cultivation kit available in micro- and deepwell plates and in shake flasks. R&D activities: Development of fed-batch cultivation media that will provide up to 50-times more bacteria and recombinant prteins/plasmid DNA than traditional cultivation methods. Categories of activity: Biotech company; Biotech support company; Production; R&D; R&D service; Supplier; Diagnostics and devices; Research reagents;
Biotech Job Partner Oy Ab Kutomotie 16, 00380 HELSINKI Finland Web site: www.biotechjobpartner.com Founded: 2002 Turnover: EUR 0,1 million Personnel: 1	Anders Laurén, Managing Director Phone: Fax: anders.lauren at biotechjobpartner.com	Production (and other) activities: Biotech Job Partner is a recruitment company. Our clients are leading biotechnology and pharmaceutical companies. Categories of activity: Biotech support company; Other service;
Biotie Therapies Oyj Tykistökatu 6, FI-20520 Turku, Finland Web site: www.biotie.com Founded: 1992 Turnover: EUR 5,6 million (2009) Personnel: 80 (2009)	Chris Piggott, Chief Business Officer Phone: +358 2 274 8900 Fax: +358 2 274 8910 chris.piggott at biotie.com Timo Veromaa, President & CEO Phone: +358 2 2748 901 Fax: +358 2 274 8 910 timo.veromaa at biotie.com	Production (and other) activities: Biotie is a drug discovery and development company focused on central nervous system and inflammatory diseases. It has a broad range of innovative small molecule and biological drug candidates at different stages of clinical and pre-clinical development. Biotie’s products address diseases with high unmet medical need and significant market potential, including addiction and psychotic disorders, rheumatoid arthritis, psoriasis and chronic obstructive pulmonary disease (COPD). The most advanced product, nalmefene for alcohol dependence, is currently in phase III clinical development by licensing partner H. Lundbeck A/S. The commercial value of the pipeline has been demonstrated through existing alliances with top-tier global pharmaceutical companies such as Lundbeck, Roche and Pfizer. Biotie has operations in Turku, Finland and Radebeul, Germany. Shares are listed on NASDAQ OMX Helsinki Ltd. R&D activities: Categories of activity: Biotech company; R&D; Drug discovery;
Biotop Oy Tykistökatu 6 B 3, FIN-20520 Turku, Finland Web site: www.biotop.fi Founded: 1992 Turnover: EUR 1 million (2008) Personnel: 4 (2008)	Risto Ranta, CEO Phone: +358 2 241 0099 Fax: +358 2 241 0111 risto.ranta at biotop.fi	Production (and other) activities: Distribution of biodiagnostic kits and molecular biology products. R&D activities: Development of novel immunoassay kits. Categories of activity: Biotech company; Biotech support company; R&D service; Supplier; Diagnostics and devices; Research reagents;
BioTurku / Turku Science Park Ltd		Categories of activity:
Biovian Oy Tykistökatu 6 B, FI-20520 Turku, Finland Web site: www.biovian.com Founded: 2003 Turnover: EUR 2.8 million (2009) Personnel: 30 (2009)	Knut Ringbom, Director Phone: Fax: knut.ringbom at biovian.com	Production (and other) activities: CMO (Contract Manufacturing) Biopharmaceuticals CDM (Contract development) Biopharmaceuticals QC (microbiolgical release testing) R&D activities: NA Core technologies: Recombinant proteins antibodies Gene therapy vectors Categories of activity: Biotech company; Biotech support company; Production; R&D service; Other service; Drug discovery; Diagnostics and devices; Biomaterials;
Bioxid Ltd		Categories of activity:
Boneca Oy		Categories of activity:
Boreal Plant Breeding Ltd		Categories of activity:
Brion Scientific Ltd		Categories of activity:
Carbozyme Ltd Keilaranta 16, FI-02150 Espoo, Finland Web site: www.carbozyme.fi Founded: 1999	Fred Fenel, Managing Director Phone: Fax: fred.fenel at carbozyme.fi	R&D activities: Development and commercialization of products and methods of protein engineering. Categories of activity: Biotech company; R&D; R&D service; Enzymes;
Cellogico Ltd.		Categories of activity:
Cel´Amanzi Oy Web site: www.celamanzi.com		Categories of activity:
Centre for metrology and accreditation FINAS		Categories of activity:
Cerebricon Ltd. Microkatu 1, FIN-70210 Kuopio, Finland Web site: www.cerebricon.com Personnel: 24	Juha Yrjänheikki, CEO Phone: +358 17 368 0801 Fax: +358 17 368 0803 juha.yrjanheikki at cerebricon.com Patrick Sweeney, Director of Business Development Phone: +358 17 368 0801 Fax: +368 17 368 0803 patrick.sweeney at cerebricon.com	Production (and other) activities: Independent contract based research company providing specialized in vitro and in vivo brain disease models for testing and developing new pharmaceutical compounds for stroke, Alzheimer´s, Parkinson, Huntington, trauma, migraine etc. R&D activities: Development of models that are crucial for studying the efficiency of drugs, resolving the mechanisms action, searching new drug candidates for brain diseases, and screening for new drug targets. Fee-based services or shared R&D projects possible. Core technologies: Validated disease models with analysis methods ranging from molecular to functional and behavioral tests. Categories of activity: Biotech company; R&D; Drug discovery;
Chempolis Oy		Categories of activity:
Chip-Man Technologies Ltd Web site: www.chipmantech.com Founded: 2002 Personnel: 4 (2004)	Korpinen Juha, CEO Phone: +358 3 3138 7046 Fax: juha.korpinen at chipmantech.com	Production (and other) activities: Chip-Man Technologies produces living cell analysis systems, which don't need any labeling or markers, also the company produces cell-based-assays which are used in these systems. R&D activities: Machine Vision, machine learning, biology, cell models, cell based assays. Core technologies: Machine Vision, machine learning, biology, cell models, cell based assays. Categories of activity: Biotech support company; R&D service; Drug discovery;
City-Lab Oy Tykistökatu 6 floor 1, FI-20520 Turku, Finland Web site: www.city-lab.fi Founded: 1993 Personnel: 5 (2005)	Päivi Kemppainen Phone: +358 2 469 1057 Fax: +358 2 469 1058 paivi.kemppainen at city-lab.fi	Production (and other) activities: We have three bioshops, one in Biocity, Turku and two others in Biomedicum and in Viikki, in Helsinki. In our shops you can shop or order reagents, consumables and small instruments from the companies we work with. Categories of activity: Biotech support company; Other service; Supplier;
Clinical Research Institute Helsinki University Central Hospital Ltd		Categories of activity:
Clinical Research Services Turku CRST Itäinen Pitkäkatu 4 B, FIN-20520 Turku, Finland Web site: www.crst.utu.fi Founded: 1995 Turnover: EUR 1 million Personnel: 23 (2009)	Anssi Himmanen Phone: +358 2 333 7635 Fax: +358 2 333 7216 anssi.himmanen at utu.fi Mika Scheinin Phone: +358 2 333 7502 Fax: +358 2 333 7216 mika.sheinin at utu.fi	Production (and other) activities: - Phase I, II and III clinical drug studies - Clinical studies of medical devices - Clinical studies of nutraceuticals and functional foods - Study design and protocol writing - Clinical Study reports - Drug and biomarker assays from clinical and non-clinical samples - Bioanalytics for REACH registration - Toxicity studies and bioanalytics of eg. biocides Categories of activity: Biotech support company; R&D service; Other service; Drug discovery; Biomaterials; Food and feed; Environment;
CNServices Oy		Categories of activity:
ConMed Linvatec Biomaterials Oy PO Box 3, FI-33721 Tampere, Finland Web site: www.linvatec.com Founded: 1984 Personnel: 60 (2005)	Kaj Koskinen, Managing Director Phone: +358 3 316 5600 Fax: +358 3 316 5688 infofinland at linvatec.com	Production (and other) activities: ConMed Linvatec Biomaterials is the leading developer and manufacturer of procedure specific medicine products. R&D activities: Research and development of bioabsorbable surgical implants and instrumentation for procedure specific applications. R&D is based on high expertise and long experience of biomaterials and on comprehensively patent protected technologies. Core technologies: ConMed Linvatec Biomaterial's products are based on innovative material advantage, combined with worldwide patents and state of the art technologies. Categories of activity: Biotech company; Production; R&D; Biomaterials;
Coronaria Feedback Oy		Categories of activity:
Crown CRO Oy		Categories of activity:
CRS Biotech Oy Torikatu 8, FI-39200 Kyröskoski, Finland Web site: www.crsbiotech.fi Founded: 1995 Turnover: EUR 0,6 million (2007) Personnel: 6 (2007)	Jari Siivari, Dr., Managing Director Phone: +358400892386 Fax: +35833714330 jari.siivari at crsbiotech.fi	Production (and other) activities: Plant extracts for nutraceutical and cosmetic industry R&D activities: Agrobiotechnology, rural development projects including natural raw materials Core technologies: Dry extract production, vacuum drying, laboratory methods for biological samples (flavonoids, streols vitamins, etc.) Categories of activity: Biotech company; Production; R&D; Biomaterials; Food and feed; Agro;
CRS-Research Ltd		Categories of activity:
CRT (CleanRoom Tech) VEHNÄMYLLYNKATU 6 33560 Tampere, Finland Web site: www.crtoy.com Founded: 1996 Turnover: EUR 1 million (2007) Personnel: 5 (2007)	Pasi Kallio, MD Phone: +358415035851 Fax: +35832540745 pasi.kallio at crtoy.com	Production (and other) activities: Cleanrooms, cleanroom devices and cleanroom products R&D activities: developing systems against harmful microbes Categories of activity: Biotech support company; Other service; Supplier; Environment;
CSC Tieteellinen Laskenta Oy		Categories of activity:
Culminatum Innovation Oy Ltd Innopoli, Tekniikantie 12, 02150 Espoo Web site: www.biobusiness.fi Founded: 1995 Personnel: 4 (2010)	Riikka Paasikivi, Program Director Phone: +358-50-5215944 Fax: +358-10 2178901 riikka.paasikivi at culminatum.fi	Production (and other) activities: Culminatum Innovation Oy Ltd is a development company owned by the Uusimaa Regional Council, the cities of Helsinki, Espoo and Vantaa, and the universities, polytechnics, research institutes and business community of Helsinki region. Culminatum Innovation manages the Centre of Expertise Programme within Helsinki Region covering nine cluster fields (period 2007 - 2013). One of them is HealthBIO - Health cluster, that promotes the creation of new business activities and the development of high-tech products and services in the field of biotechnology. Categories of activity: Other service;
CyFlo Ltd Itäinen Pitkäkatu 4 B, 20520 Turku, Finland Web site: www.cyflo.fi	Jussi Vaahtovuo, CEO Phone: +358-2-4788520 Fax: +358-2-4788521 jussi.vaahtovuo(at)cyflo.fi	Production (and other) activities: CyFlo offers microbiological and immunological research and development services for food and feed industry, life sciences sector and other industries interested in microbes. Categories of activity: Biotech company; Biotech support company; R&D; R&D service; Other service; Diagnostics and devices; Food and feed;
Cyncron Oy Metsänneidonkuja 10, FI-02130 Espoo, Finland Web site: www.cyncron.com	Anja Forsberg, Country Manager Phone: +358 9 7255 4405 Fax: +358 9 7255 4411 af at cyncron.com Benedikte Oestergaard, CEO Cyncron A/S Phone: +45 42 14 62 15 Fax: +45 70 20 20 57 boe at cyncron.com	Production (and other) activities: Cyncron is a full service contract research organization. Our strength is our deep understanding and knowledge about the Nordic Region. We have offices in Denmark, Sweden and Finland. For clinical trial activities outside of our region we work through a formal partnership. Cyncron will take your trial safely through all steps from feasibility to final report. We provide you with services on investigator selection, patient recruitment and site management. We also offer you expertise in biometrics, statistics, trial design and medical writing as well as regulatory activities and drug handling. Cyncron offers you highly professional and committed staff for out-sourcing. Try Cyncron, your reliable partner for clinical trials in the Nordic Region. References as available upon request. Categories of activity: Biotech support company; R&D service; Other service;
Danisco Technology Center Sokeritehtaantie 20, FIN-02460 Kantvik, Finland Web site: www.danisco.com Personnel: 97	Nina Rautonen, Director, Bioscience Phone: Fax: nina.rautonen at danisco.com Pekka Piiroinen, Development Director Phone: Fax: pekka.piiroinen at danisco.com	Production (and other) activities: Production Food and feed ingredients, sweeteners and speciality carbohydrates. R&D activities: Gut microbiology and physiology and immunology, nutrition, gene technology, enzymology, fermentation, separation and process technology. Core technologies: Gene Technology, Separation Technology. Categories of activity: Biotech company; R&D; Agro; Enzymes;
DelSiTech Ltd Itäinen Pitkäkatu 4 D, FI-20520 Turku, Finland Web site: www.delsitech.com Founded: 2001	Harry Jalonen, CEO Phone: +358 2 4788 640 Fax: +358 2 4788 120 harry.jalonen at delsitech.com Gunnar Björkstén, Vice President Business Development Phone: +358 2 4788 640 Fax: +358 2 4788 120 gunnar.bjorksten at delsitech.com	Production (and other) activities: DelSiTech Ltd specialises in a silica-based implant, subcutaneous and intra-muscular injectable technology for controlled release of small molecular drugs and biopharmaceuticals: proteins, polysaccharides (heparin) and viruses. Core technologies: DelSiTech(TM) is an advanced therapeutics delivery technology for implants, subcutaneous and intramuscular administration suitable for the controlled delivery of a wide range of active ingredients, including small molecules, proteins, heparin and viruses. The proprietary technology is based on silica (SiO2) matrix into which the active ingredient is embedded. The matrix can be designed to degrade at the required rate to assure a tightly controlled release of the active substance, providing a better therapeutic effect in situ and causing lower systemic toxicological side-effects than alternative delivery systems. The proof of principle has been demonstrated in animal testing both with small synthetic drugs and biologics like viruses. The technology was developed in two universities by the Biomaterial Research Group in Turku, Finland and is owned and patented by DelSiTech Ltd. Categories of activity: Biotech company; R&D; Diagnostics and devices;
Dicode Oy		Categories of activity:
Ekolab environmental Oy		Categories of activity:
Elixi Oil Oy		Categories of activity:
Elomatic Oy Itäinen Rantakatu 72, FI-20810 Turku, Finland Web site: www.elomatic.com Founded: 1970 Turnover: EUR 38 million (2006) Personnel: 600 (2006)	Aulis Rajala, Vice President Phone: +358 2 412 4311 Fax: +358 2 412 4444 aulis.rajala at elomatic.com	R&D activities: Process development, Document management program, 3D-CAD solutions, CADMATIC. Core technologies: Consulting and engineering services from feasibility studies to validation and plant start-up for pharmaceutical and biotech investment projects. 3D-design using CADMATIC and CADMATIC eBrowser, Automation systems, Clean room design and Validation services. Categories of activity: Biotech support company; R&D service;
Encorium Oy/Ltd. Keilaranta 16, FI-02150 Espoo, Finland Web site: www.encorium.com Founded: 1996 Turnover: EUR 10 million Personnel: 106 (2004)	Dr Kai Lindevall, CEO Phone: +358 20 751 82 00 Fax: +358 20 751 8250 klindevall at encorium.com Hanna Kanerva, Senior Director, Country Manager Phone: +358 20 751 8200 Fax: +358 20 751 8250 hkanerva at encorium.com	Production (and other) activities: Encorium is a Clinical Research Organisation (CRO) providing clinical research services to pharmaceutical, food and biotech companies. Encorium is a full service global CRO. Our areas of expertise are Cardiology and Cardiovascular diseases, Oncology, Immunology and Vaccines, CNS, and Endocrinology. Categories of activity: Biotech support company; Other service;
EvoStem Finland Ltd. Suntinmäentie 30, FI-36200 Kangasala, Finland Founded: 2006	Minna Leppänen, Managing Direcor Phone: +358-40-504 4423 Fax: minna.leppanen(at)evostem.com	Production (and other) activities: EvoStem develops, produces and markets stem cell therapies for veterinary use. Categories of activity: Biotech company; Production; R&D;
Faron Pharmaceuticals Oy Ltd Web site: www.faronpharmaceuticals.com Founded: 2002 Turnover: EUR 0.16 million (2004) Personnel: 1 (2004)	Markku Jalkanen, CEO Phone: +358 40 520 6124 Fax: +358 2 478 8411 markku.jalkanen at faronpharmaceuticals.com	Production (and other) activities: Drug discovery and drug development services. R&D activities: Inflammation, Cancer, Traumas, Functional foods. Core technologies: Cell trafficking and adhesion (Clever, CD73, Vap-1, CD44v6), Biologically active GAGs, Farbetics, Tumobiotics. Categories of activity: Biotech company; Biotech support company; R&D; Other service; Drug discovery; Food and feed;
FBD Oy Ltd Web site: www.fatmanbiodesigns.com Founded: 1999	Prof. Mark S. Johnson, CEO Phone: +358 40 505 9343 Fax: +358 2 215 3280 mark.johnson at fatmanbiodesigns.com	Production (and other) activities: FBD specializes in the computer-aided design of small molecule ligands on the basis of protein structural information and using bioinformational methods. Proprietary software is under development to help streamline the ligand design process. Core technologies: Protein modelling, x-ray crystallography, ligand design. Categories of activity: Biotech company; R&D service; Bioinformatics;
Fennobon Oy		Categories of activity:
Fennopharma Oy		Categories of activity:
Fermion Oy Koivu-Mankkaantie 6 A, FI-02101 ESPOO, Finland Web site: www.fermion.fi Founded: 1970 Turnover: EUR 65 million (2008) Personnel: 310 (2008)	Hanspeter Ros, Vice President, CRAMS Phone: 050 966 4004 Fax: 010 426 4424 hanspeter.ros at orion.fi	Production (and other) activities: Contract manufacturing of active pharmaceutical ingredients for the innovative and generic drugs industry R&D activities: Chemical synthesis, chiral compounds, scale-up Core technologies: cytotoxic agents, high-potent active pharmaceutical ingredients Categories of activity: Production; R&D; Drug discovery;
Fermlab Oy Lemminkäisenkatu 30, FI-20520, Turku, Finland Web site: www.fermlabs.com Founded: 2000 Personnel: 2	Ari Båtsman, Managing Director Phone: +358 2 2410012 Fax: +358 50 5731828 ari.batsman at fermlab.fi	Production (and other) activities: Manufacturing, sales and marketing of research reagents and probiotic bacteria. Subcontract manufacturing and services to diagnostic, biopharma and food industry and related research institutes. R&D activities: Research and development of probiotic bacteria applications. Core technologies: Research reagents: purification of CNS based proteins. Probiotic bacteria: Functional effects, stability and other properties. Process optimization. Categories of activity: Biotech company; Biotech support company; Production; R&D service; Other service; Supplier; Drug discovery; Diagnostics and devices; Food and feed; Enzymes; Research reagents;
Fibrogen Europe Oy Viikinkaari 6, 00790 Helsinki, Finland Web site: www.fibrogeneurope.com Founded: 1995 Personnel: 2 (2009)	Dr Juha Koivurinta Phone: +358 9 563 73 221 Fax: +358 9 563 73 224 jkoivurinta at fibrogeneurope.com	Production (and other) activities: Pilot production of different collagen types. R&D activities: Development of different collagen types, mainly types I, II, III and different collagen fragments (gelatins) for pharmaceutical and medical device use. Core technologies: Production of stable recombinant human collagens and gelatin using the patented multi-gene technology. Categories of activity: Biotech company; Supplier; Biomaterials;
Finn-Medi Research Ltd Finn-Medi Science and Business Park Biokatu 12, FI-33529 Tampere, Finland Web site: www.finnmediresearch.com Founded: 1995 Turnover: EUR 2 million Personnel: 14	Matti Eskola, Managing Director Phone: +358 3 3116 4020 Fax: +358 3 3116 4029 matti.eskola at finnmedi.fi Tiina Kärjä-Lahdensuu, Research Manager Phone: + 358 3 3116 4034 Fax: + 358 3 3116 4029 tiina.karja-lahdensuu at finnmedi.fi	Production (and other) activities: Finn-Medi Research offers expertise and services for health and biotechnology companies, researchers and pharmaceutical industry. Customers represent from biotechnology start-ups up to major pharmaceutical companies. Services include clinical trials (phase I-IV), business development and licensing, R&D consulting and project management. Finn-Medi Research also coordinates biotechnology development programs such as BioneXt Tampere and Centre of expertise programme. Bionext Tampere is 100 milion investment and development programme that focuses on immunology and vaccines, biomaterials and tissue technology and applied information technologies. Categories of activity: Biotech support company; Biotech centre; R&D service; Other service;
Finnfeeds Finland Ltd (trading as Danisco Animal Nutrition) Sokeritehtaantie 20, FIN-02460 Kantvik, Finland Web site: animalnutrition.danisco.com Founded: 1998 Turnover: EUR 35 million Personnel: 80	Juhani O. Kuusisto, Managing Director Phone: +358 10 4314686 Fax: +358 10 4314333 juhani.kuusisto at danisco.com	Production (and other) activities: Production Production facility in Naantali producing betaine and other molasses based fine chemicals. Core technologies: Cromatographic separation. Categories of activity: Biotech company; Production; Food and feed; Enzymes;
Finnfeeds Ltd (trading as Danisco Animal Nutrition) PO Box 461, FIN-65101 Vaasa, Finland Web site: animalnutrition.danisco.com Founded: 1991 Turnover: EUR 35 million Personnel: 16	Juhani O. Kuusisto, Managing Director Phone: +358 10 4314686 Fax: +358 10 4314333 juhani.kuusisto at danisco.com Rainer Skinnar, Plant Manager Phone: +358 10 4313508 Fax: +358 10 4313500 rainer.skinnar at danisco.com	Production (and other) activities: Production Production facility in Vaasa producing feed enzymes. Categories of activity: Biotech company; Production; Food and feed; Enzymes;
Finnish Red Cross Blood Service Kivihaantie 7, FIN-00310 Helsinki, Finland Web site: www.veripalvelu.fi Founded: 1947 Turnover: EUR 70 million (2005) Personnel: 500 (2005)	Jukka Partanen, Research Director Phone: +358 9 5801298 Fax: +358 9 5801429 jukka.partanen at veripalvelu.fi	Production (and other) activities: Blood and blood-related products; laboratory service for organ and stem cell transplantation; laboratory services related to haemostasis, coagulation and blood grouping. R&D activities: Stem cells; tissue banking; services for organ and stem cell transplantation. Core technologies: In R&D: Cell and molecular biology; genomics and genetics; Categories of activity: Biotech company; R&D; Other service;
Finnish seed potato centre Ltd./Suomen siemenperunakeskus Oy		Categories of activity:
Finnoflag Oy PO Box 262, FIN-70110 Kuopio, Finland Web site: www.finnoflag.com Founded: 1993	Elias Hakalehto, PhD Phone: +358 500 574 289 Fax: +358 17 282 2838 finnoflag at co.inet.fi	Production (and other) activities: Production Microbe samplers and sample treatment devices, reagents, services. R&D activities: Tests for rapid microbe diagnostics, new innovative tools for microbiology. Core technologies: New microbe detection and sampling technologies, development of health promoting substances. Categories of activity: Biotech company; R&D; Diagnostics and devices;
Finnvera Oy		Categories of activity:
Finnzymes Oy Keilaranta 16 A, FI-02150 Espoo, Finland Web site: www.finnzymes.com Founded: 1986 Personnel: 89 (2009)	Pekka Mattila, CEO Phone: +358 9 2472 3010 Fax: +358 9 2472 3200 fz at finnzymes.fi	Production (and other) activities: Thermostable DNA polymerases, other enzymes for molecular biology, PCR instruments and consumables, PCR-based diagnostics. Core technologies: PCR, diagnostics. Categories of activity: Biotech company; Production; R&D; Supplier; Diagnostics and devices; Enzymes;
FIT Biotech Oy Biokatu 8, FI-33520 Tampere, Finland Web site: www.fitbiotech.com Founded: 1995 Personnel: 37 (2008)	Kalevi Reijonen, CEO & President Phone: +358 33138 7000 Fax: +358 3 3138 7050 kalevi.reijonen at fitbiotech.com	Production (and other) activities: FIT Biotech Plc is an innovative medical biotechnology company engaged in the development and commercialization of its proprietary Gene Transport Unit (GTU®) technology and GTU product applications in DNA vaccination and immune therapy. The company's other areas of expertise are artificial immunogen, recombinant protein and antibody technologies, as well as GMP grade process development and production of DNA vaccines. In addition, the company has developed and launched test kits for the detection of natural latex allergens. FIT Biotech was established in 1995 and is located in Tampere, Finland, with operations also in Tartu, Estonia. R&D activities: Leveraging its GTU technology platform, FIT Biotech has built a strong product pipeline that comprises a therapeutic HIV vaccine, a preventive HIV vaccine, as well as vaccines for melanoma, diabetes and hepatitis C. FIT Biotech's HIV vaccine programs have already progressed to the Phase I/II stage. Core technologies: GTU technology: applicable to DNA vaccination as well as to immuno and gene therapies for the modulation of the immune system via antigens or cytokines for use in the treatment of infectious diseases, cancer and allergies. Categories of activity: Biotech company; Production; R&D; R&D service; Supplier; Drug discovery; Diagnostics and devices;
Fluilogic Oy Westendinkuja 25 B, FI-02160 Espoo, Finland Web site: www.fluilogic.fi Founded: 1978 Personnel: 1	Ilkka Talvinen Phone: +358 40 555 0294 Fax: +358 102 961 307 ilkka.talvinen at fluilogic.fi	Production (and other) activities: Production sale and markeitng of EMB-dispenser (electromagnetic actuator) modules and MAB-dispenser (mechanical actuator) modules R&D activities: Development of dispenser systems for dispense range of 50 nanoliters to 1000 microliters. Core technologies: EMB-technology, a Fluilogic patented dispenser technology. Categories of activity: Biotech support company; Production; R&D; Diagnostics and devices;
Foodfiles Oy Ltd Neulaniementie 2 L 6, FI-70210 Kuopio, Finland Web site: www.foodfiles.com Founded: 1998 Personnel: 10 (2004)	Dr Essi Sarkkinen, Managing and Research Director Phone: +358 17 288 1261 and Fax: +358 17 288 1269 essi.sarkkinen at foodfiles.com Ms Pirjo-Leena Kinanen-Nimmrichter, Administrative Manager Phone: +358 17 288 1270 and Fax: +358 17 288 1269 pirjo-leena.kinanen-nimmrichter at foodfiles.com	R&D activities: Clinical studies for food and pharmaceutical industry, regulatory affairs (food, food ingredients) for food industry, consultation in nutrition and health claims. Categories of activity: Biotech support company; R&D service; Food and feed;
Foodwest Oy		Categories of activity:
FRH Technology Partnership Oy Ltd Neitsytpolku 2b A 15-16, FIN-00140 Helsinki, Finland Founded: 2003 Personnel: 3	Kai Falck, Senior Partner Phone: +358 50 5233 683 Fax: +358 9 638 724 kai.falck at welho.com Päivi Ryöppy, Senior Partner Phone: +358 50 536 5233 Fax: +358 9 638 724 paivi.ryoppy at welho.com	Production (and other) activities: Management consulting, creating international partnerships, business development services, analysis and studies on life science sector. Categories of activity: Biotech support company; R&D service; Other service; Drug discovery; Diagnostics and devices; Food and feed; Agro; Environment;
Functional Foods Forum		Categories of activity:
Galanthia Web site: www.galanthia.com		Categories of activity:
Galena Ltd		Categories of activity:
Galilaeus Oy Kairiskulmantie 10, PO Box 113, FI-20781 Kaarina, Finland Web site: www.galilaeus.fi Founded: 1994 Personnel: 27 (2005)	Kristiina Ylihonko, CEO Phone: +358 2 274 1450 Fax: +358 2 273 1460 kristiina.ylihonko at galilaeus.fi	Production (and other) activities: Contract manufacturing of New Chemical Entities (NCE's) and small volume intermediates or on-market active ingredients. Galilaeus has GMP compliant fermentation facility for the manufacture of small molecule pharmaceuticals, also cytostatics. Process development for small molecule fermentation including strain construction/improvement, optimisation of fermentation conditions, downstream development, scale-up. R&D activities: Development of highly efficient fermentation processes for technologically demanding active pharmacetical ingredients and NCE's. Core technologies: Control of biosynthetic pathways in microbes by genetic engineering. Natural products chemistry. Categories of activity: Biotech company; Biotech support company; Production; R&D;
GE Healthcare Turku Imanet Oy		Categories of activity:
Genano Oy Ltd Kimmeltie 3, FI-02110 Espoo,Finland Web site: www.genano.fi Founded: 1999 Turnover: EUR 1,5 million (2008) Personnel: 5 (2009)	Mikael Rentto, Managing Director Phone: +35897743870 Fax: mikael.rentto at genano.fi Klaus Nissinen, Vice Preseident Phone: +35897743870 Fax: klaus.nissinen at genano.fi	Production (and other) activities: Genano air cleaning units R&D activities: Developing own patented Genano technology Core technologies: Genano air cleaning technology can remove particles, microbes and volatile organic chemicals down to 0.001microns in size with up to 99.5% efficiency. We use our air cleaning systems in dental labs, hospitals, hotels and anywhere else people are suffering from poor indoor air quality. Categories of activity: Biotech support company; Other service; Biomaterials; Environment; Enzymes; Research reagents;
Genencor International Oy PO Box 13, FIN-42301 Jämsänkoski, Finland Web site: www.genencor.com Founded: 1990 Turnover: EUR 62 million Personnel: 200	Jouni Viljanen Phone: +358 14 7494 400 Fax: +358 14 7494 410 jviljanen at genencor.com Aino Mansikkamäki Phone: +358 19 2804 300 Fax: +358 19 2804 307 amansikkamaki at genencor.com	Production (and other) activities: Production Industrial enzymes and industrial fermentations. Core technologies: Manufacturing of industrial enzymes. Categories of activity: Biotech company; Production; Enzymes;
Genolyze Ltd PO Box 140, FIN-20521 Turku, Finland Web site: www.genolyze.com Founded: 2003 Personnel: 7	Marko Mäenpää, CEO Phone: +358 50 4616530 Fax: +358 10 633 8189 marko.maenpaa at genolyze.com	Production (and other) activities: Genolyze is bioinformatics research Service Company specializes in enhancing research, development and production processes by applying Bio-IT know-how. Company’s mission is to save researchers time and grow the value of measured data by revealing the useful information hidden into the massive data and complex multivariable studies. R&D activities: Computational methods for biological data, Biomarkers, Biological data management Core technologies: Sophisticated data analysis and computational methods, Mathematical and statistical modelling, Data management, IT and Bio-database systems. Categories of activity: Biotech company; Biotech support company; R&D service; Other service; Bioinformatics;
GenoSyst Ltd. Itäinen Pitkäkatu 4B, FI-20520 Turku, Finland Web site: www.genosyst.com Founded: 2006 Personnel: 7 (2007)	Robert Hermann, CEO Phone: +358 2 478 8360 Fax: + 358 2 478 8120 robert.hermann at genosyst.com Attila Gyenesei, Director of Research and Development Phone: +358 2 478 8360 Fax: + 358 2 478 8120 attila.gyenesei at genosyst.com	Production (and other) activities: GenoSyst Ltd. offers software and data analysis services for various domains of biosciences and bioindustry, with special focus on systems biology applications: transcriptomics - global gene expression profiling, genomics - disease gene mapping, proteomics and metabolomics. Additionally we provide in silico tools for drug discovery. R&D activities: GenoSyst Ltd. carries out research and development in the following areas: novel data mining techniques for whole genome association scans, whole genome sequence patterns discovery, global expression profiling, in silico HTS drug discovery - QSAR, maximal common substructures. Core technologies: Applications of advanced mathematics to uncover hidden knowledge in large scale biological datasets, advanced statistics, data mining. Categories of activity: Biotech company; Production; R&D; Other service; Bioinformatics;
Genxpres Ltd		Categories of activity:
Glykos Finland Oy		Categories of activity:
H. Lundbeck Oy Ab		Categories of activity:
HaartBio Oy Ab Haartmaninkatu 3, FI-00290 Helsinki, Finland Web site: www.haartbio.fi Founded: 2003	Marja-Liisa Lokki, Managing Director Phone: Fax:	Production (and other) activities: Operates between university and biotechnological and medical companies marketing academic know-how and products. Categories of activity: Biotech support company; Other service;
Headman Ltd Porttitie 11 D, FIN-02180 Espoo, Finland Web site: www.headman.fi Founded: 1992 Personnel: < 10	Klaus Hedman, MD, Professor Phone: +358 50 5249 086 Fax: klaus.hedman at helsinki.fi	Production (and other) activities: Diagnostics for infectious diseases. R&D activities: Diagnostics for infectious diseases; outsourced R&D; diagnostic consultation. Core technologies: IgG-avidity and epitope-type specificity serodiagnostics; other innovative antibody-EIA techniques; recombinant protein expression; molecular biology; quantitative PCR. Categories of activity: Biotech company; R&D; Diagnostics and devices;
Helsinki Business and Science Park Ltd Viikinkaari 4, FI-00790 Helsinki, Finland Web site: www.hbsp.net Founded: 1992 Turnover: EUR 2,8 million Personnel: 15 (2008)	Pia Westerling Phone: Fax: Antti Sekki, Business Development Director Phone: +358 9 319 36 543 Fax: +358 9 319 36 554 antti.sekki at hbsp.net	Production (and other) activities: Helsinki Business and Science Park (HBSP) provides a dynamic business environment with a diversified research and expert network and a Centre of Expertise within food technology, biotechnology, drug development and diagnostics, as well as environmental technology. HBSP operates in two campuses within the City of Helsinki, in Viikki Biocampus and in Meilahti Medical Campus. Categories of activity: Biotech centre; Other service;
Hermo Pharma Oy		Categories of activity:
Hi-Col Ltd		Categories of activity:
Hidex Oy		Categories of activity:
Histola Research Oy Niittyhaankatu 20, FI-33720 Tampere Web site: www.histola.com Founded: 2004 Personnel: 10 (2008)	Pia Kivijärvi, Managing Director Phone: +358 20 7432 007 Fax: +358 20 7432 001 pia.kivijarvi at histola.fi Katja Veneskoski, Laboratory Manager Phone: +358 20 7432 002 Fax: +358 20 7432 001 katja.vaneskoski at histola.fi	Production (and other) activities: Histola Research Ltd is a contract research organization that offers testing and tailored experts services for non-clinical operations. Histola is having GLP accredited laboratory premises. Our services covers from research planning to practical arrangements and project management. We are committed to long term high quality co-operation and cost-efficient expertise in the implementation of non-clinical operations. • IN VITRO TOXICOLOGY AND CELL BIOLOGICAL RESEARCH • HISTOTECHNOLOGY (Immunohistochemistry) • ENVIRONMENTAL RESEARCH, ECOTOXICITY TESTING AND CONSULTANCY • NANOSAFETY • CHEMICAL TESTING (REACH) AND CONSULTANCY • PROJECT MANAGEMENT SERVICES AND CONSULTANCY Categories of activity: Biotech support company; R&D; R&D service; Other service; Supplier; Drug discovery; Diagnostics and devices; Biomaterials; Bioinformatics; Environment;
Hormos Medical Corp. - a subsidiary of QuatRx Pharmaceuticals Company USA Itäinen Pitkäkatu 4, FIN-20520 Turku, Finland Web site: www.hormos-med.com Founded: 1997 Turnover: EUR 2 million (2004) Personnel: 38 (2004)	Dr Risto Lammintausta, CEO Phone: +358 2 410 8000 Fax: +358 2 410 8001 risto.lammintausta at hormos-med.com	Production (and other) activities: QuatRx Pharmaceuticals Company, a biopharmaceutical company, focuses on research and development of therapeutic compounds primarily for the treatment of major endocrine, metabolic and cardiovascular diseases, especially dyslipidemia and endocrine diseases of aging. QuatRx has its headquarters in Ann Arbor, Michigan, with a significant presence in Europe through Hormos Medical Corp., a wholly-owned subsidiary of QuatRx Pharmaceuticals Company. R&D activities: The research activities of the company are based on its expertise in tissue-specific steroid hormone effects at the molecular and cellular level. Currently running projects in the indication areas of menopausal symptoms, androgen deficiency disorders, dyslipidemia. Core technologies: The company's core technologies include selective estrogen receptor modulators (SERM), selective androgen receptor modulators (SARM) and hydroxysteroid dehydrogenase (HSD) inhibitors. Categories of activity: Biotech company; R&D; Drug discovery;
Hycail Finland Oy Tykistökatu 4D, FI-20520 Turku, Finland Web site: www.hycail.fi Founded: 2004 Turnover: EUR 0,5 million (2008) Personnel: 3 (2009)	Svante Wahlbeck, Managing Director Phone: +358-400 828326 Fax: svante.wahlbeck at hycail.fi	Production (and other) activities: Biopolymer analytical services and R&D services R&D activities: Biomaterials product development Core technologies: PLA (lactic-acid based polymers) Categories of activity: Biotech company; Biotech support company; R&D; R&D service; Biomaterials;
Hytest Ltd. PharmaCity, Itäinen Pitkäkatu 4C, FI-20520 Turku, Finland Web site: www.hytest.fi Founded: 1994 Turnover: EUR 3,2 million (2003) Personnel: 24 (2003)	Jukka Lehikoinen Phone: +358 2 512 0900 Fax: +358 2 512 0909 jukka.lehikoinen at hytest.fi Susanna Brink Phone: +358 2 512 0900 Fax: +358 2 512 0909 susanna.brink at hytest.fi	R&D activities: HyTest is continuously working to bring new products to the market as well as improving the existing ones through R&D. Our R&D specialists maintain close ties with the scientific community and engage in joint research with the Finnish academic diagnostic research organizations. Core technologies: HyTest has become a leading supplier of several reagents worldwide (such as antibodies and antigens of the troponin complex or native human thyroid peroxidase), at the same time maintaining a broad range of other products. Categories of activity: Biotech company; Production; R&D; Diagnostics and devices;
Imanext Oy/Ltd. Aleksanterinkatu 17, FI-00100 Helsinki, Finland Web site: www.imanext.com Founded: 2006	Kim Bergström, CEO Phone: +358 40 415 5741 Fax: +358 10 296 0313 kim.bergstrom at imanext.com	Production (and other) activities: Imanext Ltd. provides molecular imaging applications for drug development to the pharmaceutical and biotechnology industry. Imanext is a niche CRO (Contract Research Organization), and is operating in the field of translational imaging. Imanext’s services include nonclinical proof-of-concept studies using a wide spectrum of SPECT/PET (Single Photon Emission Computed Tomography / Positron Emission Tomography) tracers, and clinical phase I/II SPECT (including phase 0 and microdosing) studies. Imanext operates with its partners globally. Categories of activity: Biotech support company; Other service;
Immuno Diagnostic Oy Kaivokatu 16, FI-13100 Hämeenlinna, Finland Web site: www.immunodiagnostic.fi Founded: 1983 Turnover: EUR 4,0 million (2008) Personnel: 10 (2008)	Dr Marko Laine, Vice President, Sales Director Phone: +358 3 6153 725 Fax: +358 3 6822 039 marko.laine at immunodiagnostic.fi Mr Jarmo Laakkonen, Vice President, CEO Phone: +358 3 6153 726 Fax: +358 3 6822 039 jarmo.laakkonen at immunodiagnostic.fi	Production (and other) activities: Marketing of kits for ultra-rapid immunohistochemical staining on frozen sections. Distribution of reagents, chemicals and instruments for research and diagnostic applications.ISO9001:2000 certificate. R&D activities: Technology transfer, commercialization and consulting. Categories of activity: Biotech company; Biotech support company; Production; R&D service; Supplier; Drug discovery; Diagnostics and devices; Biomaterials; Food and feed; Agro; Environment; Enzymes; Research reagents;
info@bnpands.com		Categories of activity:
Inion Oy Lääkärinkatu 2, FI-33520 Tampere, Finland Web site: www.inion.com Founded: 1999 Personnel: 95 (2004)	Chris Lee, CEO Phone: +44 (0) 1483 685 390 Fax: chris.lee at inion.com Julien Cotta, CFO Phone: +44 (0) 1483 685 390 Fax: julien.cotta at inion.com	Production (and other) activities: Inion is dedicated to developing and manufacturing novel medical devises based on innovative biomaterials. Inion developed solutions feature a range of proprietary technologies and processes that offer significant benefits over alternative methods and have won a growing number of the customers around the world. Priority is given to solutions that can be used quickly and easily, save valuable OR time and are priced competitively. Inion's product range includes biodegradable products for the following surgical applications: Craniomaxillofacial (Inion CPS), Orthopaedics (Inion OTPS), Sports medicine (Hexalon, Trinion) and dental (Inion GTR membrane). R&D activities: Inion's material and product testing is carried out at the company's special R&D laboratory at the headquarters, equipped with state-of-the-art manufacturing, laboratory and office facilities as well as class 10 000 clean room. Materials analysis work is also carried here, and at the reasearch centres and universities around the world. Core technologies: Polymer science and processing technology are the core technologies of Inion. Categories of activity: Biotech company; Production; R&D; Biomaterials;
Innofinance Oy		Categories of activity:
Innokas Medical Oy		Categories of activity:
Innomedica Oy Tykistökatu 6 B (BioCity), FI-20520 Turku, Finland Helsinki office: Tukholmankatu 8 B FIN-00290 Helsinki, Finland Web site: www.innomedica.fi Founded: 1997	Tanja Dowe, Managing Director Phone: +358 400 636 107 Fax: +358 2 2748 420 innomedica at innomedica.fi	Production (and other) activities: Innomedica is a service provider for the Life Science industry. Our main service products are: Japan Partnering, Project Management Services, Business Development, Internationalisation. Using our experienced team of Life Science Professionals, we can help our clients to get the best our of their technologies and product ideas. Innomedica is your Partner in Life Sciences. Categories of activity: Biotech support company; Other service;
Innotrac Diagnostics Oy Biolinja 12, FI-20720 Turku, Finland Web site: www.innotrac.fi Founded: 1995 Personnel: 45	Hannamaija Fontell, Marketing Director Phone: +358 2 278 4000 Fax: +358 2 278 4001	Production (and other) activities: Production and marketing of the Innotrac Aio!TM Immunoassay systems and reagents for cardiac and critical care testing in emergency environments. Contract manufacturing services in streptavidin coated plate and diagnostic reagent production for diagnostics, pharmaceutical companies and research institutions. R&D activities: Development of rapid, quantitative immunoassay systems and reagents for point-of-care and central laboratory testing. Core technologies: All-in-one dry chemistry technology and non-enhancement time-resolved fluorometry (TRF). Categories of activity: Biotech company; Production; R&D; R&D service; Other service; Supplier; Diagnostics and devices;
Institute for Molecular Medicine Finland FIMM		Categories of activity:
Institute of Biotechnology Core Facilities and Service Units P.O.Box 56 (Viikinkaari 9), FI-00014 University of Helsinki, Finland Web site: http://www.biocenter.helsinki.fi/bi/		Production (and other) activities: The Institute of Biotechnology is an administratively independent unit of the University of Helsinki. The mission of the Institute is to promote high-level research and education in biotechnology, molecular biology, cell biology, and related areas. The Institute has the-state-of-the-art facilities in its R&D units, which offer services to researchers at the University as well as in industry. Categories of activity: R&D; R&D service;
Inveni Capital Oy		Categories of activity:
Invenire Market Intelligence Oy Kokkilantie 835, FI-25230 Angelniemi, Finland Web site: www.invenire.fi Founded: 2003	Patricia Wiklund, Managing Director Phone: +358 (0)40 8228848 Fax: patricia.wiklund(at)invenire.fi	Production (and other) activities: Invenire provides commercialisation support and market research. We have a professional and entrepreneurial team working internationally in the business of food and nutrition. Categories of activity: Biotech support company; Other service; Biomaterials; Food and feed; Agro;
IP Finland Oy		Categories of activity:
JFP Executive Search Oy		Categories of activity:
JVS-Polymers Inc Innopoli, Tekniikantie 12, FI-02150 Espoo, Finland Founded: 1994	Dr Jukka Seppälä, Chairman of the Board Phone: +358 9 251 73 430 Fax: jvs at innopoli.fi	R&D activities: - Polymer technology and engineering - Biopolymers technologies Core technologies: - Biodegradable polymer technologies - Biomedical polymers Categories of activity: Biotech company; R&D; Biomaterials;
Jyväskylä Innovation Oy Piippukatu 11, 40100 Jyväskylä Web site: www.jklinnovation.fi Founded: 2006	Veli-Pekka Heikkinen, Managing Director Phone: +358 40 5399 214 Fax: veli-pekka.heikkinen at jklinnovation.fi	Categories of activity: Biotech company; Biotech support company; Biotech centre; Other service; Biomaterials; Bioinformatics; Environment;
Kaivogen Oy Tykistökatu 4D, FI-20520 Turku, Finland Web site: www.kaivogen.com Founded: 2007 Turnover: EUR 0,6 million (2008) Personnel: 7 (2009)	Leena Kokko, Managing Director Phone: +358 50 5900853 Fax: leena.kokko at kaivogen.com	Production (and other) activities: Production of protein coated microtiter plates (main product streptavidin coated plates) Customised reagent production Categories of activity: Biotech company; Production; Research reagents;
Kibron Inc. Upseerinkatu 3 A, 02600 Espoo, Finland Web site: www.kibron.com Founded: 1994	Jukka Kilpiö, Managing Director Phone: +358 9 6811 920 Fax: +358 9 6811 9222 info at kibron.com Jana Nyrén, Marketing Director Phone: +358 9 6811 920 Fax: +358 9 6811 9222 info at kibron.com	Production (and other) activities: Kibron develops and manufacturers analyzers and assays for the pharmaceutical and chemical industries as well as academic surface chemistry research. Categories of activity: Biotech company; Production; R&D; Drug discovery; Diagnostics and devices; Environment; Research reagents;
kirsi.varmo@hus.fi		Categories of activity:
Kojair Tech Oy		Categories of activity:
Kolster Oy Ab Iso Roobertinkatu 23, FI-00121 Helsinki Web site: www.kolster.com Founded: 1874 Turnover: EUR million Personnel: 185 (2008)	Monica Lax, Branch Manager, Biotechnology and Chemistry Phone: +358 9 618 821 Fax: +358 9 602 244 monica.lax at kolster.fi	Production (and other) activities: The mission of Kolster is to protect and manage our customers' intellectual property and support the development of industrial property rights. Our company has highly experienced resources in IP prosecution, especially in patenting in high-technology fields such as biotechnology and ICT. Our biotech team consists of 12 experts in biotechnology, genetics and chemistry. This team has gathered a great deal of experience in protecting biotechnology applications, most recently in the use of stem cells in diagnostics, micro arrays in cancer therapy and diagnostics, and probiotics in the food industry. Categories of activity: Biotech support company; Other service;
Konstrumed Oy		Categories of activity:
Kuomed Oy		Categories of activity:
Kuopio Innovation Ltd. PO Box 1188, Microkatu 1, FIN-70211 Kuopio, Finland Web site: www.kuopioinnovation.fi Founded: 2008 Turnover: EUR 2,3 million (2008) Personnel: 20	Heikki Nuutinen, Managing Director Phone: +358 500 674 413 Fax: +358 17 441 2011 heikki.nuutinen at kuopio.fi	Production (and other) activities: Kuopio Innovation Ltd. helps local technology enterprises develop domestic and international business activity. It promotes cooperation between business and research aiming to the creation of new business activities. The focus of operation is in the fields of health, environment and wellbeing. The core of the operation is the Centre of Expertise Programme and its related development projects. More information: www.kuopioinnovation.fi. Categories of activity: Biotech support company; Biotech centre; R&D service;
Labmaster Oy Fiskarsinkatu 11, FI-20750 Turku, Finland Web site: www.labmaster.fi Founded: 1986 Personnel: 9	Teppo Laaksonen, Managing Director Phone: +358 2 276 0556 Fax: +358 2 276 0550 teppo.laaksonen at labmaster.fi	Production (and other) activities: Development, manufacturing and marketing of immunodiagnostic kits and reagents for applications in functional food research (metabolic end products of lignans and isoflavonoids) and routine clinical diagnostics (coeliac disease, osteoporosis, cardiac diseases). R&D activities: Labmaster Oy is developing new technology for clinical, biochemical and chemical analysis like also PCR analysis based on cathodic electrochemiluminescence (ECL) and application of microelectronics. Core technologies: Time-resolved fluoroimmunoassay, ELISA, cathodic electrochemiluminescence, microfabrication of silicon. Categories of activity: Biotech company; Production; R&D; Diagnostics and devices;
Laborexin Oy Holkkitie 14, PO Box 224, FI-00811 Helsinki, Finland Web site: www.laborexin.fi Founded: 1980 Turnover: EUR 0.6 million (2008) Personnel: 6 (2008)	Pentti Tanskanen, Managing Director Phone: +358 9 780 633 Fax: +358 9 781 393 pentti.tanskanen at laborexin.fi Timi Tanskanen, Product Manager Phone: +358 9 780 633 Fax: +358 9 781 393 timi.tanskanen at laborexin.fi	Production (and other) activities: The company is specializing in manufacturing and marketing first class laboratory technology and glassblowing products. In addition, we represent numerous international laboratoryglass, equipment and biotechnology companies. R&D activities: Our goal is to cocentrate in technology transfer, where innovations in the academic research are developed to put them in the practice. Core technologies: Laboratory glassblowing, equipments, DNA Electrophoresis Kits, Protein Assays, Liphophilic Ionsensitive Electrodes. Categories of activity: Biotech support company; Production; R&D service; Supplier; Diagnostics and devices; Environment; Research reagents;
leena.eskola@atostek.com		Categories of activity:
Licentia Ltd Tukholmankatu 8 A, FI-00290 Helsinki, Finland Web site: www.licentia.fi Founded: 2001 Turnover: EUR 1,5 million (2004) Personnel: 7		Production (and other) activities: Commercialization of research results and technologies (.Technology transfer). Technology and IP consulting. Categories of activity: Biotech support company; Other service; Drug discovery; Diagnostics and devices; Bioinformatics; Food and feed; Research reagents;
Life-Science-Man Oy Ltd Keilaranta 16, FI-02150 Espoo, Finland Web site: www.lifescience.fi Founded: 2002 Personnel: 5 (2004)	Anu Harkki,, Managing Director, PhD, MBA Phone: +358 9 8133 800 Fax: +358 9 8133 828 harkki at lifescience.fi Anu Mehtonen, Head of Regulatory Affairs, MSc Phone: +358 9 8133 801 Fax: +358 9 8133 828 mehtonen at lifescience.fi	Production (and other) activities: Business and regulatory services for life science and chemical industries. - Management consulting services - Food regulatory affairs services - Chemical registration services (REACH Management) - Clinical studies and contract research services Categories of activity: Biotech support company; R&D service; Other service; Bioinformatics; Food and feed; Agro; Environment;
Lightlake Sinclair Ltd.		Categories of activity:
LP Research Centre Ltd		Categories of activity:
Macrocrystal Oy Ruukintie 20 F, FI-02320 Espoo, Finland Web site: www.macrocrystal.com Founded: 1993 Personnel: 4		Production (and other) activities: Crystallization process development by contracts with biotech and pharmaceutical companies. Production of crystalline proteins for laboratory use. R&D activities: Developing macromolecule crystallization methods. Developing new reagents for crystallization. Methods of technical handling of crystal batches. Core technologies: Crystallization of enzymes, proteins and peptides in large scale for commercial production purposes. Formulation of products on the basis of crystallization. Purification by crystallization. Categories of activity: Biotech company; Production; R&D service; Drug discovery; Biomaterials; Enzymes; Research reagents;
Magnasense Ltd Nanoscience Center, Survontie 9, FI-40500 JKL, Finland Web site: www.magnasense.com Founded: 2003 Personnel: 5	Mika Laitinen, CEO Phone: +358 40 5435989 Fax: mika.laitinen at magnasense.com Jari Salmela, R&D Manager Phone: Fax: jari.salmela at magnasense.com	R&D activities: Development of magnetometric lateral flow assay reader is going on. Magnasense also participates several research projects in the areas of magnetic particles and microfluidistics. Core technologies: Magnasense technology is based on the use of magnetic microspheres as labels and on the measurement of change on magnetization in the capture zone of a test. The diagnostic measuring instrument forms an easy to use quantitative biosensor when combined with disposable test cartridges. Either traditional sandwich assay or competitive assay formats can be used to form the capture zone. Detection method is suitable for e.g. proteins, steroids, drugs of abuse, nucleic acids, bacteria and viruses. Categories of activity: Biotech company; R&D service; Supplier; Diagnostics and devices;
Maininki PTC Oy Kulttuuritehdas Korjaamo, Töölönkatu 51 B, FI-00250 Helsinki, Finland Web site: www.maininki.com Founded: 2004	Sirpa Pietilä, CEO Phone: +358 40 556 5268 Fax: +358 20 7417 001 sirpa.pietila at maininki.com	Production (and other) activities: Maininki PTC is specialized in effective communication and informative campaigns. Maininki PTC has special knowledge in biotechnology and is for example in charge of the national www.bioteknologia.info campaign. Categories of activity: Biotech support company; Other service;
MAP Medical Technologies Oy		Categories of activity:
MCA Research Laboratory Ltd BioCity, Tykistökatu 6 B, FI-20520 Turku, Finland Web site: www.mcaresearchlaboratory.com Founded: 1992 Personnel: 4 (2006)	Markku Ahotupa, Chairman of the Board Phone: +358 2 241 0142 Fax: +358 2 241 0143 res.lab at mca.inet.fi	Production (and other) activities: Biochemical and toxicological research services (laboratory studies and consulting) for industry and research institutions. R&D activities: Oxidative stress related diseases. Core technologies: Testing of antioxidant activity: from in vitro models to human studies. Availability of biomarkers for lipid, protein and DNA oxidation. Categories of activity: Biotech company; Biotech support company; R&D service; Supplier; Drug discovery; Diagnostics and devices; Food and feed; Environment;
Meda Oy		Categories of activity:
Medeia Therapeutics Oy Microkatu 1, FI-70211 Kuopio, Finland Web site: www.medeiatherapeutics.com Founded: 2006	Milla Koistinaho, CEO Phone: +358-44-590 0603 Fax: +358-44-659 00603 milla.koistinaho(at)medeiatherapeutics.com	R&D activities: Medeia is engaged in the discovery and early development of novel therapies for diseases of the central nervous system. Categories of activity: Biotech company; R&D; Drug discovery;
Medical Interscience Talents M.I.T. Consulting Ltd Mannerheimintie 12 B, 5th floor, Helsinki PO Box 16, FI-00601 Helsinki, Finland Web site: www.mitconsulting.fi Founded: 1990 Turnover: EUR 0,2 million (2005) Personnel: 4 (2009)	Esa Soppi, President, CEO Phone: + 358 40 524 2728 Fax: + 358 9 728 7064 esa.soppi at mitconsulting.fi	Production (and other) activities: Medical Interscience Talents M.I.T. Consulting Ltd “Doing things that stand viewing and reviewing in the arena of life sciences” provides services creating of added business value and hands on operational execution, as well as state of art methodology and innovative customized solutions to resolve challenging customer problems. Strategy & operations: 1) Strategy audit & strategy development, 2) Portfolio and project assessment & value maximation, 3) Research & opportunity assessment, 4)Operative performance& process excellence. Development services: 1) Refinement of drug & device development process, 2) Risk assessment & management, 3) CRO & central laboratory contracting, 4) SOP management process. Core technologies: Proprietary methodology for portfolio management and valuation/value creation. Categories of activity: Biotech support company; R&D service;
Medicall Finland Oy Ab		Categories of activity:
MediCel Oy Web site: www.medicel.com Founded: 2001 Personnel: 45 (2005)	Risto Renkonen, Managing Director Phone: +358 9 1912 5111 and Fax: +358 9 1912 5155	R&D activities: MediCel's Systems Biology software development aims to gather, sort, analyse and understand the wide diversity of biological data from various pre-existing databases as well as from our own biological experiments. We also annotate and generate systematically the biochemical pathways and finally convert the huge amount of biological data into knowledge. This will allow us to generate models of biological processes, which could be further tested and iterated by both in vitro, ex vivo and in vivo experiments. Categories of activity: Biotech company; R&D; Bioinformatics;
MediFront Ltd. Tykistökatu 6 B, FIN-20520 Turku, Finland Web site: www.medifront.fi Founded: 1999 Personnel: 3	Tapio Rautaoja, Marketing Director Phone: +358 2 4699254 Fax: +358 2 4699255 tapio.rautaoja at medifront.fi	Production (and other) activities: Markets special pharmaceuticals like orphan drugs to hospitals. Categories of activity: Biotech company; Supplier; Drug discovery;
Medikalla Oy - MediPharmia	Tuija Keinonen (Ph.D.Pharm.), Managing Director Phone: +358 17 288 1231 Fax: tuija.keinonen at medikalla.fi	Production (and other) activities: Contract manufactoring and packaging of pharmaceutical products. Analytical and microbiological analysis of pharmaceutical products and raw materials. R&D activities: Research and development of pharmaceuticals products. Categories of activity: Biotech company; Production; R&D service;
Medikro Oy		Categories of activity:
Medipolis GMP Oy Kiviharjuntie 2, FI-90220 Oulu, Finland Web site: www.medipolisgmp.com Founded: 2001 Turnover: EUR 1 million Personnel: 15 (2005)	Dr. Ashesh Kumar, Director Phone: +358 400 207 380 Fax: kumar.ashesh at medipolisgmp.com	Production (and other) activities: Medipolis GMP Ltd is a CMO that offers process development, fermentation, downstream and spporting QA / QC services for companies that need manufacturing of biopharmaceuticals for preclinical, clinical trials and even commercial purposes. We are looking for parters in EU for FP-7 program and offer our excellent team for process development and GMP material production for Clinical studies R&D activities: BioPAT- Process Development, Clinical Development of Biopharmaceuticals Core technologies: Microbial fermentation with related process development and downstream processes. Categories of activity: Biotech company; Production;
Medisize Oy Robert Huberin tie 3 A, FI-01510 Vantaa, Finland Web site: www.medisize.com Founded: 2006 Turnover: EUR 128 million (2009) Personnel: 900 (2009)	Seppo Arento, Varatoimitusjohtaja, CTO Phone: +358 40 55 88 202 Fax: +358 (0)9 5629 1130 seppo.arento at medisize.com Juha Laiho, Manager, Technology development Phone: +358 40 52 51 296 Fax: +358 (0)9 5629 1130 juha.laiho at medisize.com	Production (and other) activities: Medisize is an international contract manufacturer specialised in medical devices for delivery and administration of drugs and pharmaceutical packaging as well as development, manufacture and distribution of single-use plastic products for anaesthesia and intensive care. Medisize offers services from design to mass production. Operations are conducted in four segments as well as mould manufacturing; Drug Delivery Devices, Medical & Diagnostics Devices, Primary Pharmaceutical Packaging and Airway Management. R&D activities: High speed manufacturing of precision injection moulded components and assemblies, materials and application driven development Core technologies: Concept design, industrialization and mechanical design, prototyping and tool manufacturing, high volume precision injection moulding and assembly in clean room environment, filling and final packaging, gamma sterilisation , logistics Categories of activity: Biotech company; Biotech support company; Production; R&D service; Supplier; Diagnostics and devices;
Medix Biochemica Oy Ab Asematie 13 , FI-02700 Kauniainen, Finland Web site: www.medixbiochemica.com Founded: 1985 Turnover: EUR 10,6 million (2008) Personnel: 85 (2008)	Mr. Ismo Råman, Managing Director Phone: +358 9 547680 Fax: +358 9 5053441 ismo.raman at medixbiochemica.com	Production (and other) activities: Production Monoclonal antibodies and rapid diagnostic tests. R&D activities: Monoclonal antibodies and rapid diagnostic tests. Core technologies: Antibody technology and applications. Categories of activity: Biotech company; Production; R&D; Diagnostics and devices;
Melius Pharma Oy		Categories of activity:
Merck Oy		Categories of activity:
MetGen Oy		Categories of activity:
Metkinen Oy		Categories of activity:
Mobidiag Oy Tukholmankatu 8 (Biomedicum 2), FI-00290 Helsinki, Finland Web site: www.mobidiag.com Founded: 2000 Personnel: 18 (2010)	Aleksi Soini, CEO Phone: +358 9 191 25021 Fax: +358 9 191 25020 aleksi.soini at mobidiag.com Sari Valasti, Office Manager Phone: +358 9 191 25021 Fax: +358 9 191 25020 sari.valasti at mobidiag.com	Production (and other) activities: Mobidiag´s core products are DNA biochips for the rapid identification of important microbial pathogens directly from patient samples. R&D activities: Mobidiag is developing solutions for the user-friendly and cost-effective analysis of biochip test results. Core technologies: Mobidiag´s technology uses a patented univelsal approach to identify microbial species. This technology allows the rapid simultaneous detection of a large panel of organisms from a single sample. Categories of activity: Biotech company; R&D; Diagnostics and devices; Bioinformatics;
MSD Finland Oy		Categories of activity:
MTT Agrifood Research Finland		Categories of activity:
Mylab Oy Hatanpään valtatie 26, FI-33100 Tampere, Finland Web site: www.mylab.fi Founded: 1987 Turnover: EUR 9 million (2008) Personnel: 53 (2008)	Esa Soini, CEO Phone: +358 3 3165165 Fax: +358 3 3165166 Jukka Kalliosaari, Corporate Relations Manager Phone: +358 3 3165165 Fax: +358 3 3165166	Production (and other) activities: Mylab produces information services and IT systems for clinical laboratories R&D activities: Business intelligence, systems integration, automated verification, advanced LIS, analyzer interfaces and web-based applications Categories of activity: Biotech support company;
Mzymes Oy		Categories of activity:
Nab Labs Oy Betonimiehenkuja 1 A, 02150 Espoo Web site: www.nablabs.fi Founded: 2003 Turnover: EUR 8 million (2008) Personnel: 120 (2009)	Mikko Sainio, VP, Business Development Phone: +358 40 588 1679 Fax: mikko.sainio at nablabs.fi Markku Ahponen, CEO Phone: +358 40 543 7887 Fax: markku.ahponen at nablabs.fi	Production (and other) activities: Nab Labs provides a wide scope of laboratory services. Ad hoc samples or long-term analytical support contracts. Categories of activity: Biotech support company; R&D service; Other service;
Nanobac Oy Neulaniementie 2 L 14, FI-70210 Kuopio, Finland Web site: www.nanobac.com Founded: 1998 Personnel: 7	Olavi Kajander, Managing Director Phone: +358 17 265 8900 Fax: +358 17 265 8933 olavi.kajander at nanobac.com Katja Aho, Director R&D Phone: +358 17 265 8900 Fax: +358 17 265 8933 katja.aho at nanobac.com	Production (and other) activities: Components and test assays for nanobacteria detection, like antigen and antibody detection by ELISA assays and quick test. Core technologies: Culture systems, antigen and antibody detection methods. Categories of activity: Biotech company; Production; R&D; R&D service; Other service; Supplier; Drug discovery; Diagnostics and devices; Biomaterials;
Net-Foodlab Ltd Voimakatu 19, FIN-20520 Turku, Finland Web site: www.netfood.fi Founded: 1997 Personnel: 10	Tuomas Virtalaine, M.Sc. Phone: +358 2 2730 891 Fax: +358 2 2730 880 tuomas.virtalaine at netfood.fi Anu Johansson, Ph.D. Phone: +358 2 2730 893 Fax: +358 2 2730 880 anu.johansson at netfood.fi	Production (and other) activities: Analytical laboratory services. Production hygiene and quality control services. Distribution, method development and validation for Celsis and Hygiena rapid diagnostics systems. Categories of activity: Biotech support company; R&D service; Other service; Supplier; Diagnostics and devices; Food and feed; Environment;
Nexstim Oy		Categories of activity:
Next Biomed Technologies NBT Oy Biomedicum Helsinki 2U, Tukholmankatu 8, FI-00290 Helsinki, Finland Web site: www.nextbiomed.com Founded: 2006 Personnel: 12 (2009)	Ilari Antila, CEO Phone: +35894540420 Fax: +35894540421 ilari.antila at nextbiomed.com	Categories of activity: Biotech company; Production; R&D; Diagnostics and devices;
NNE Pharmaplan Finland		Categories of activity:
Nordic Envicon Oy		Categories of activity:
Norlab Ltd		Categories of activity:
Novagenesis Oy Biomedicum Helsinki 2 U, Tukholmankatu 8, FIN-00290 Helsinki, Finland Founded: 2006 Personnel: 9 (2009)	Kauko Kurkela, Managing Director Phone: +358 50 310 6848 Fax: +358 10 440 5401 kauko.kurkela at novagenesis.fi	R&D activities: The Company specializes in the development of unique regeneration products for nervous system. Categories of activity: Biotech company; R&D; Diagnostics and devices;
Novamass Ltd Kiviharjuntie 11, FIN-90220 Oulu, Finland Web site: www.novamass.net Founded: 2002 Personnel: 11 (2009)	Jouko Uusitalo, CEO Phone: +358 207 639 669 Fax: +358 207 639 660 jouko.uusitalo at novamass.net	Production (and other) activities: We provide ADME contract research for drug discovery and development. Our core competences are in vitro drug metabolism studies (metabolic stability and metabolite identification), metabolism related drug interaction studies, and permeation studies of NCEs and related pharmacology. We also provide custom analysis based on LC/MS and NMR techniques and quantitative bioanalysis (eg. in vivo animal DMPK studies). R&D activities: Our services include metabolic stability, metabolite identification, metabolizing CYP enzyme identification, CYP inhibition and induction, cell line permeation, BBB penetration and in vivo metabolism studies. Our studies predict in vivo ADME properties of NCEs in man and are used to lead optimisation and selection of candidate drugs. Core technologies: Human and animal liver preparations. Determination of physicochemical ADME parameters, protein binding and permeability. Chemical purity and degradation. Liquid Chromatography combined with Mass Spectrometry (LC/MS), NMR. Analytical method development and validation. Bioanalysis. Categories of activity: Biotech support company; R&D service; Drug discovery;
Novobion Oy		Categories of activity:
Oligomer Oy Latokartanonkaari 11, D-talo, 00790 Helsinki, Finland Web site: www.oligomer.fi Founded: 2004 Turnover: EUR 0,5 million (2009) Personnel: 3 (2009)	Veli-Pekka Karvinen, Managing Director Phone: +35897552550 Fax: +358975525555 veli-pekka.karvinen at biofellows.com Matti Laakso, Production Chemist Phone: +358934789010 Fax: +358934789090 matti.laakso at oligomer.fi	Production (and other) activities: Production of synthetic oligonucleotides, DNA and RNA. Categories of activity: Biotech company; Production; R&D; Research reagents;
Onbone Oy Linnoitustie 4 A, 02600 Espoo, Finland Web site: www.onbone.com Founded: 2008	Petro Lahtinen, CEO Phone: +358 50 5811033 Fax: petro.lahtinen (at) onbone.com	Production (and other) activities: Onbone commercialises and markets innovative proprietary medical devices used in the field of orthopaedic and traumatology treatments R&D activities: Onbone relies on constant product development and innovation of new solutions in order to fulfill user demands Core technologies: Biopolymers, composite biomaterials Categories of activity: Diagnostics and devices; Biomaterials;
OneMed Oy PO Box 11, FI-01641 Vantaa, Finland Web site: www.onemed.com Founded: 1999 Turnover: EUR 200 million (2006) Personnel: 14 (2006)	Aarno Saarelainen, Marketing Manager Phone: +358 20 445 4720 Fax: +358 20 445 4717 aarno.saarelainen at onemed.com	Production (and other) activities: Sales and marketing of Life Science products for biotech and drug discovery companies. Categories of activity: Biotech support company; Supplier; Research reagents;
Optomed Oy (Ltd) Hallituskatu 13-17 D 96, FI-90100 Oulu, Finland Web site: www.optomed.fi Founded: 2004 Turnover: EUR 0,05 million (2008) Personnel: 10 (2008)	Seppo Kopsala, CEO Phone: +358 40 555 1050 Fax: seppo.kopsala at optomed.fi	Production (and other) activities: Optomed Oy is a pioneering medical technology company that specializes in digital imaging devices both for human and veterinary medicine. Categories of activity: Biotech support company; R&D; Diagnostics and devices;
OrFix Oy		Categories of activity:
Orion Corporation Orion Pharma Orionintie 1 A, PO Box 65, FI-02101 Espoo, Finland Web site: www.orionpharma.com Founded: 1917 Turnover: EUR 641,1 million (2006) Personnel: 3 061 (total) (2006)	Matti Vaheri, Director, CNS Business Phone: +358 10 4261 Fax: +358 10 426 3815 matti.vaheri at orionpharma.com Reijo Salonen, Senior Vice President, Research & Development Phone: +358 10 4261 Fax: +358 10 426 3600 reijo.salonen at orionpharma.com	Production (and other) activities: Production pharmaceuticals, active pharmaceutical ingridients and diagnostic point of care -test systems. R&D activities: Drug discovery and development on three core therapeutic areas: CNS, cardiovascular diseases and critical care, hormone replacement therapies and urology, as well as animal health. Core technologies: All major techniques for drug development from molecule to market. Categories of activity: Biotech company; Production; R&D; Drug discovery; Diagnostics and devices;
Orion Diagnostica Oy PO Box 83, FI-02101 Espoo, Finland Web site: www.oriondiagnostica.fi Founded: 1974 (as an independent divisi Turnover: EUR 39,3 million (2004) Personnel: 318 (2004)	Jaakko Rissanen, President Phone: + 358 10 429 4858 Fax: + 358 10 429 2794 jaakko.rissanen at oriondiagnostica.fi	Production (and other) activities: Production, sales and marketing of Diagnostic tests and test systems, monoclonal antibodies, protein purifucation and modification, dip-slide manufacturing, Large scale antibody production (poly and mono), Microparticles. R&D activities: Focusing on point of point-of-care test systems and special analytes: H. pylori, CRP, bone markers, anemia markers, steroid hormones. Core technologies: Analyte know-how, Multiple assay technologies, Microparticle technology. Categories of activity: Biotech company; Production; R&D; Supplier; Diagnostics and devices;
Orthotopix Ltd		Categories of activity:
Osteofix Oy		Categories of activity:
Oulu Innovation Oy / Bio Forum Oulu Elektroniikkatie 6, FI-90570 Oulu, Finland Web site: www.ouluinnovation.com Founded: 2004	Olli Löytynoja, Vice President Phone: +358 8 551 3005 Fax: +358 8 551 3627 olli.loytynoja at ouluinnovation.com Tuula Palmén, Program Director Phone: +358 50 461 7290 Fax: +358 207 545 879 tuula.palmen at bioforumoulu.org	Production (and other) activities: Development projects within Life Sciences incl. biotechnology. The convergence of BIO with Nano, IT and Eco. Categories of activity: Biotech support company; Other service;
Oy Cardiocode-Finland Ltd.		Categories of activity:
Oy Medfiles Ltd Volttikatu 5, FI-70700 Kuopio, Finland Web site: www.medfiles.fi Founded: 1987	Tuija Keinonen, Managing Director, Ph.D.Pharm. Phone: +358 20 7446 802 Fax: +358 20 7446 801 tuija.keinonen at medfiles.fi Tuija Keinonen, Managing Director, Ph.D.Pharm Phone: +358 20 7446 802 Fax: +358 20 7446 801 tuija.keinonen at medfiles.fi	Production (and other) activities: MedFiles Ltd is a private Contract Research Organization (CRO) with strong, over 20 years, experience.In Europe, our geographical focus is in Scandinavian countries (Finland, Sweden, Denmark, Norway) and Baltic states (Estonia, Latvia and Lithuania). The areas of expertise include pharmaceutical development, product updating and full range of analytical services (chemical and microbiological), clinical research services (phase I to IV studies) and marketing authorisation services (regulatory affairs). R&D activities: Research and development of pharmaceutical products Categories of activity: Biotech company; R&D; R&D service; Other service;
Patiq Oy Westendintie 1b FI-02160 Espoo Web site: www.patiq.com Founded: 2007	Antti Pirnes, Chairman, Patent Analyst Phone: +358 10 4211302 Fax: +358 10 4211309 antti.pirnes at patiq.com	Production (and other) activities: Patiq is a Finland based technology intelligence company. We use the most powerful commercial data banks to analyze patent information on product, technology and market changes in order to increase our client’s decision-making quality and competitiveness. Our promise to you is to guide you to stay on track in your research and development projects, enable you to commercialize your technology and stay ahead of your competitors. We are a company with several years of expertise in patent analysis in various technology fields. Categories of activity: Biotech support company; R&D; R&D service; Other service; Drug discovery; Diagnostics and devices; Biomaterials; Bioinformatics; Food and feed; Agro; Environment; Enzymes; Research reagents;
PCAS Finland Oy Messukentänkatu 8, FI-20101 Turku, Finland Web site: www.pcasfinland.fi Founded: 1960 Turnover: EUR 11 million (2004) Personnel: 120 (2004)	Jussi Torikka, President Phone: +358 2 3305457 Fax: +358 2 3305500 info at pcasfinland.com Reino Isotalo, Sales Director Phone: +358 2 3305907 Fax: +358 2 3305500 info at pcasfinland.fi	Production (and other) activities: PCAS Finland Oy develops, manufactures and markets fine chemicals for the pharmaceutical industry. Our product portfolio consists of Active Pharmaceutical Ingredients (APIs) and Custom Manufactured Products for our clients. R&D activities: We provide the following R&D services for our clients: development of laboratory synthesis for new chemical entities, scaling-up processes to a commercial scale, development of analytical procedures to be used in quality control The key areas of our research and development are: synthetic research and development, reaction calorimetry for safety studies, analytical research and development, assistance for regulatory documentation. Core technologies: The key technologies used in custom manufacturing are: chlorination (chlorine in bulk), hydrogenation, optical resolution, bisphosphonate chemistry, reduction with alkyl metal hydrides, final processing for parenteral/injectable APIs. PCAS Finland Oy also relies on PCAS S.A. corporate resources (6 plants) for cGMP (300 m3 reactor volume) and non GMP (400 m3 reactor volume) chemical synthesis. Categories of activity: Production; R&D; R&D service; Other service; Supplier; Drug discovery;
PerkinElmer Wallac Oy Mustionkatu 6, FIN-20101 Turku, Finland Web site: www.perkinelmer.com Founded: 1950 Turnover: EUR 100 million Personnel: 650	Hanna Halme, General Manager Phone: +358 2 267 8339 Fax: +358 2 267 8357 hanna.halme at perkinelmer.com Kauko Lamminpää, Sales Manager Phone: +358 2 267 8464 Fax: +358 2 267 8305 kauko.lamminpaa at perkinelmer.com	Production (and other) activities: Production Final assembly and testing of instruments, reagent production and labelling service. R&D activities: Research of new technologies related to genetic screening and drug discovery applications. Product development regarding total solutions including instrumentation, chemistry and software. Applications for clinical diagnostics, bioanalytical research and drug discovery. Categories of activity: Biotech company; Production; R&D; Diagnostics and devices;
Pfizer Oy		Categories of activity:
PG Quality Oy		Categories of activity:
Pharmatest Services Ltd Itäinen Pitkäkatu 4 C, 5th floor, FI-20520 Turku, Finland Web site: www.pharmatest.fi Founded: 1997 Turnover: EUR 0.7 million (2008) Personnel: 14 (2008)	Jussi Halleen, CEO Phone: +358 50 3809551 Fax: +358 2 2784710 jussi.halleen at pharmatest.fi	R&D activities: Development of new in vitro and in vivo methods useful for pre-clinical testing of drug candidates for osteoporosis and related bone disorders. Core technologies: Various in vitro and in vivo models useful for pre-clinical testing of drug candidates for osteoporosis and related bone disorders. Categories of activity: Biotech company; R&D; Other service;
Pharmatory Ltd PO Box 346, FI-90101 Oulu, Finland Web site: www.pharmatory.com Founded: 2001 Turnover: EUR 2-3 million (2008) Personnel: 23 (2009)	Jaana Karjalainen, Managing Director Phone: +358 44 270 7271 Fax: +358 20 765 9985 jaana.karjalainen at pharmatory.com Johanna Heffernan, International Marketing & Logistics Manager Phone: +358 40 502 5281 Fax: +358 20 765 9985 johanna.heffernan at pharmatory.com	Production (and other) activities: Pharmatory specializes in the custom contract research and development and cGMP manufacturing of the APIs and the key intermediates from micro to pilot scale. The key components in all projects are customer intimacy and operational excellence with high confidentiality. Pharmatory is routinely inspected by the regulatory authorities since 2001. R&D activities: State-of-the-art analytical facility, stability studies according to ICH guidelines, impurity profiling, broad range expertise of the organic chemistry, process optimization, labelling services, identification of critical process parameters. Core technologies: Process validation at the level of regulatory authorities documentation, class C clean room area for final handling, control of the API development process, the quality and regulatory know-how, characterization of chiral molecules. Categories of activity: Biotech support company; Production; R&D; R&D service; Drug discovery;
Pharmavir Oy Aapontie 11 B 1, FI-02180 Espoo, Finland Founded: 2003 Personnel: 1 (2004)	Kauko Kurkela, President and CEO Phone: +358 500 536 742 Fax: +358 9 502 3591	Production (and other) activities: Pharmavir offers expert consulting services in the field of pharmaceutical, biotech and biomaterial industry. Management, R&D, business development, product and product portfolio strategy and planning. Consulting services both in strategic- and operational areas. Categories of activity: Biotech support company; Other service; Drug discovery; Diagnostics and devices; Biomaterials;
Pharmia Oy Kalliotie 2, FI-04360 Tuusula, Finland Web site: www.pharmia.com Founded: 1993 Turnover: EUR 4,9 million (2008)	Kari Pulkkinen, Managing Director Phone: +358 9 8254 030 Fax: +358 9 870 9715 info at pharmia.fi	Production (and other) activities: Contract manufacturing, product development and formulation of Food supplements and Medical Decice Class I. Product forms : tablets, hard gelatin capsules, liquids and powder-mixes. Packaging in blisters, jars, bottles and cartons. Categories of activity: Biotech support company; Production; R&D; Food and feed;
PLD Finland Oy Hannuksentie 1, 02270 ESPOO, Finland Web site: www.pld.fi Founded: 1998 Turnover: EUR 2 million (2009) Personnel: 10 (2009)	Tomi Virtanen, Managing Director Phone: +358 207 410 270 Fax: +358 207 410 270	Core technologies: PLD Finland Oy is a leading supplier of laboratory instruments, consumables and reagents. Our core competence is in laboratory automation, microtiter plate instruments, cell and molecular biology, clean room technology and in cryo technical products. Our biggest suppliers are Tecan, Caliper Life Sciences, PAA Laboratories, Porvair Sciences, Varian, Büchi, MVE Chart and Planer Biomed. Feel free to contact us by email sales[at]pld.fi. Our web pages You can find at www.pld.fi Categories of activity: Biotech support company; Other service; Supplier; Diagnostics and devices; Research reagents;
PlexPress Oy Tekniikantie 21, FI-02150 Espoo, Finland Web site: www.plexpress.fi Founded: 2007 Personnel: 4 (2007)	Juhani Lahdenperä, CEO Phone: 050-3669502 Fax: juhani.lahdenpera at plexpress.fi	Production (and other) activities: Service, kit & software manufacturing enabling multiplex gene expression analyses by TRAC. PlexPress has been noted to be the one of the most successful start-up:s in Finnish Biotech sector last year. PlexPress is a spin-out company of VTT (Technical Researh Center of Finland). R&D activities: TRAC platform development. Core technologies: TRAC (TRanscriptional Analysis with aid of affinity Capture) technology uniquely satisfies the gene fingerprint/function analysis market requirements. Its efficiency, flexibility and reliability are superior at the market place. TRAC technology enables the analysis of tens of genes from hundreds of samples in high efficient manner compared to current offering by other companies. Categories of activity: Biotech company; Production; Research reagents;
Pohjoisen Kantaperuna/ Northern Seed Potato		Categories of activity:
Polttimo Companies Ltd PO Box 22, FI-15141 Lahti, Finland Web site: www.polttimo.com Founded: 1883 Turnover: EUR 87 million (2004) Personnel: 233 (2004)	Katharina Stenholm, CEO Phone: +358 3 864 11 Fax: +358 3 781 0823 katharina.stenholm at polttimo.com Juha Ylä-Anttila, Business Development Director Phone: +358 3 864 11 Fax: +358 3 752 2742 juha.yla-anttila at polttimo.com	Production (and other) activities: Production Yeast, malt and malt extracts. R&D activities: LP Research Centre Ltd. Core technologies: Fermentation, malting, extraction, separation, concentration. Categories of activity: Biotech company; Production; Food and feed;
Premedic Clinical Research Ltd		Categories of activity:
PricewaterhouseCoopers Oy		Categories of activity:
Primus International Oy Ltd Iso Roobertinkatu 3-5 D 10, FI- 00120 HELSINKI, Finland Web site: www.primusfives.com Founded: 1998 Personnel: 1	Arja Kuittinen, CEO, M.Sc.(Biol), BBA, TMC Phone: +358 50 300 0351 Fax: arja.kuittinen at primusfives.com	Production (and other) activities: Services to small and mid-size Finnish and Global companies with a special expertise in Life Sciences, Biotechnology and CRO. Proven track record and experience in Turnaround of Finnish Operations of a Global Corporate and Local SME’s, Re-organization and Restructuring, Strategic Partnerships, Interim CEO and Executive Board Memberships, Global and Local Networks, Fund raising from Venture Capital Organizations, Internationalisation processes, Leadership and Business Operations Management. Categories of activity: Biotech support company; Other service;
Project Consult Technopro Oy Tuomiokirjkonkatu 3 d 24 Web site: www.technopro.fi Founded: 1988 Turnover: EUR 0,3 million (2008) Personnel: 1 (2008)	Pekka J Nieminen, Man.dir Phone: +358 400 620453 Fax: +358 10 296 0622 pekka.nieminen at technopro.fi	Production (and other) activities: Agent of LSMW GmbH Germany in Finland and Estonia Categories of activity: Biotech support company; Other service;
Quintiles Oy		Categories of activity:
Raisio plc		Categories of activity:
Reactionlab Oy PO Box 120, FI-20521 Turku, Finland Web site: www.reaction-lab.com Founded: 2001	Olli Suominen Phone: +358 40 778 9838 Fax: +358 2 4101123 olli.suominen at reaction-lab.com	Production (and other) activities: Reactionlab is offering marketing services in Nordic countries in the fields of diagnostics and biotechnology. Core technologies: Molecular Biology, Molecular Medicine,Food and Pharmaceutical Research, Immunoassay, Luminescence, Fluorescence, Transfections,Liquid Handling, Special Reagents. Categories of activity: Biotech support company; Other service; Diagnostics and devices;
Reagena Oy Ltd Takojantie 18, FI-70900 Toivala, Finland Web site: www.reagena.fi Founded: 1987 Turnover: EUR 1,3 million (2008) Personnel: 16 (2008)	Dr Markku Parviainen, PhD, Managing Director, CEO Phone: +358 17 368 8504 Fax: +358 17 368 8530 markku.parviainen at reagena.fi Ms Kati Ryynänen, MSci, Marketing Manager Phone: +358 17 368 8505 Fax: +358 17 368 8530 kati.ryynanen at reagena.fi	Production (and other) activities: Production of in vitro diagnostic (IVD) products such as biological staining solutions and test kits. Manufacturer of ReaMobile™ point-of-care diagnostic system with different POC tests. Reagents according to Ph.Eur. Along with the product line of high quality liquid-based reagents, we are engaged in contract development and production for other industries. We supply liquid-based reagents and solutions to our industrial partners as contract manufacturer. R&D activities: Point-of-care testing (R&D, manufacturing, commercialisation of innovations). Core technologies: New ReaMobile™ Test System is based on REASCAN™ rapid test reader with ReaLink™ Bluetooth device and ReaMobile™ software on a mobile phone or a PC, and our new proprietary immuno-chromatography technology. The ReaMobile™ test system is versatile for quantitative and qualitative applications in clinical chemistry, virology, and microbiology. Categories of activity: Biotech company; Production; R&D; R&D service; Supplier; Diagnostics and devices; Research reagents;
Regea Institute for Regenerative Medicine Biokatu 12, 33520 Tampere Web site: www.regea.fi Founded: 2003 Turnover: EUR 3,5 million (2008) Personnel: 50 (2009)	Riitta Suuronen, Director, Professor Phone: +358 400 473 640 Fax: + 358 3 3551 8498 riitta.suuronen at regea.fi	Production (and other) activities: The Regea Institute for Regenerative Medicine is a joint institute under the administration of the University of Tampere, having been founded by the University of Tampere, Tampere University of Technology, Pirkanmaa Hospital district, Pirkanmaa University of Applied Sciences and the Coxa Hospital for Joint Replacement. Regea engages in research in cell and tissue engineering, the focal areas being stem cell research and research combining stem cells and biomaterials. Regea Tissue Bank meets the requirements of the current Finnish legislation and also EU Directives for tissue banking. It processes and supplies tissues for clinical use. The business idea of Regea also extends to improving the operating preconditions of research groups and companies in the field. Some of the Regea laboratory and cleanroom facilities and equipment are available for rent to research groups and enterprises and for training purposes. R&D activities: Regea's stem cell research aims at developing new clinical treatments utilizing cell and tissue engineering as well as regenerative medicine. Core technologies: Tissue engineering, regenerative medicine, stem cell research. Categories of activity: Biotech centre; Production; R&D; Other service;
Remedal Oy		Categories of activity:
Replicon Oy ALeksanterinkatu 17, P.O.Box 800, FIN-00101, Helsinki, Finland Web site: www.replicon.fi Founded: 1993 Turnover: EUR 0,15 million (2008) Personnel: 4 (2008)	Petteri Hirvonen, CEO Phone: +358 50 552 96 33 Fax: +358 10 2960313 petteri.hirvonen at replicon.fi	Production (and other) activities: Replicon Group provides investment bank services and strategic solutions that facilitate business activities, efficiency, and increase the profitability of corporations and other organizations. Replicon Group's special focus areas are Life Science, Cleantech and ICT sectors. Our core services include: - Corporate Finance - Valuation services - Strategic consulting - Business Plans - R&D activities: Research on listed US biotech companies performance (Replicon Biotech Model portfolio) Core technologies: Monte Carlo simulations in drug development Categories of activity: Biotech support company; Other service; Drug discovery; Diagnostics and devices; Environment;
Rintekno Group PO Box 146, FI-02101 Espoo, Finland Web site: www.rintekno.com Founded: 1970 Turnover: EUR 25 million (2006) Personnel: 230 (2006)	Esa Aittomäki, Marketing Director Phone: +358 9 46 98 331 Fax: +358 9 466 311 esa.aittomaki at rintekno.fi Reino Kalmari, Executive Vice President Phone: +358 9 4698 362 Fax: +358 9 466 311 reino.kalmari at rintekno.fi	Production (and other) activities: Full range of engineering and project management services for the Life Science Industry and Chemical Process Industry. We design and build production facilities beginning with a process development as a partner in client's R&D team and going through pilot scale tests to a commissioned and validated plant. We deliver pilot and production scale facilities on turn-key basis as well. We have designed and built R&D facilities and production scale plants for blood plasma fractionation, fermentation, enzyme manufacturing, pharmaceutical production, food stuff and natural extractives production. R&D activities: Client specific modelling of processes and unit operations, process development, scale-up and process optimization. Core technologies: Engineering, Procurement, Construction and Project Management services. Commissioning and Start-up services. Conceptual design, Basic engineering and Project implementation services. Process development and simulation services. Validation services. Project and process risk assessment. Plant Life Cycle analysis. Hazard process analysis. Categories of activity: Biotech support company; Other service; Supplier; Food and feed; Agro; Environment; Enzymes;
Roal Oy PO Box 57, Tykkimäentie 15, FI-05201 Rajamäki, Finland Web site: www.roal.fi Founded: 1992 Turnover: EUR 33 million (2007) Personnel: 102 (2009)	Pekka Kekki, Managing Director Phone: +358 9 29042 140 Fax: +358 9 29042 114 pekka.kekki at roal.fi Jari Vehmaanperä, Research Director Phone: +358 9 29042 120 Fax: +358 9 29042 112 jari.vehmaanpera at roal.fi	Production (and other) activities: Industrial enzymes for food, feed, beverage, textile, detergent and P&P applications. R&D activities: Discovery and cloning of novel enzymes for existing and new applications. Strain improvement and process development. Core technologies: Trichoderma production technology. Industrial enzymes (particularly cellulases and hemicellulases). Categories of activity: Biotech company; Production; R&D; Supplier; Enzymes;
Roschier Attorneys Ltd.		Categories of activity:
Sanquin Oy		Categories of activity:
Santen Oy		Categories of activity:
Scaffdex Oy P.O.Box 27, FI-33411 Tampere, Finland Kalkunkatu 21 B, FI-33330 Tampere, Finland Web site: www.scaffdex.com Founded: 2006 Personnel: 3 (2006)	Tuija Annala, Managing Director Phone: +358-40-505 3351 Fax: tuija.annala at scaffdex.com	Production (and other) activities: Tissue engineering means the renewal processing of biological tissues by means of cells, support structures and/or biomolecules. Scaffdex Oy provides researchers and the industry of the professional area CellCrown cell culture inserts and various biodegradable structures, which are suitable for cell culture studies. R&D activities: Scaffdex Oy works in close cooperation with the technical institutes of fibre materials science and biomaterials of Tampere University of Technology and Regea Institute for Regenerative Medicine as well as with many other international cooperation partners. Core technologies: Expertise in various biomaterials, fibres and textile structures Categories of activity: Biotech company; Biomaterials;
Serres Oy		Categories of activity:
SLP Innovations Oy Tykistökatu 4D, FI-20520 Turku, Finland Web site: www.slpinnovations.com Founded: 2006	Sanna Paakkonen, Managing Director Phone: +358408418283 Fax: +358 2 4101710 sanna at slpinnovations.com	Production (and other) activities: SLP Innovations offers a range of solutions that will enhance the commercialisation and internationalisation of biotechnology. These solutions includes International Technology Transfer, R&D Partnering, Biobusiness Training and Roadshows. The services allow you to choose the combination of solutions that best fits the stage of your technological development and the specific goals for which you may require external services. Categories of activity: Biotech support company; Other service;
Software Point Oy Valkjärventie 1, FIN-02130 Espoo, Finland Web site: www.softwarepoint.com Founded: 1992 Turnover: EUR 5 million Personnel: 30	Andrea Holmberg, Managing Director Phone: +358 9 4391 320 Fax: +358 9 4391 3211 info at softwarepoint.fi	Production (and other) activities: Software Point provides information management software for laboratories, quality control and research. Categories of activity: Biotech support company; Other service;
SoluCel Ltd		Categories of activity:
StatFinn Oy Linnankatu 9 b A 1 Web site: www.statfinn.fi Founded: 2005 Personnel: 9 (2009)	Pekka Heikkilä, CEO Phone: +358503216006 Fax: pekka.heikkila at statfinn.fi Pasi Korhonen, CSO Phone: +358503652990 Fax: pasi.korhonen at statfinn.fi	Production (and other) activities: We provide statistical and data management services to customers conducting experimental research in the various fields of life sciences. Our focus is on proper application of statistical methods in planning, analysis and reporting of clinical and non-clinical studies. Full scale CRO services from planning to final report are provided together with our partners. Categories of activity: Biotech support company; R&D service; Other service; Drug discovery; Diagnostics and devices; Biomaterials; Food and feed;
Stick Tech Ltd P.O.Box 114, FIN-20521 Turku, Finland Web site: www.sticktech.com Founded: 1997 Personnel: 13 (2009)	Jyrki Kurokallio, Managing Director Phone: +358 2 4808 2500 Fax: +358 2 241 0032 jyrki.kurokallio at sticktech.com	Production (and other) activities: Production fibre reinforcements R&D activities: Research with fibre reinforcements with worlds top researchers and universities. Core technologies: Fibre reinforcements Categories of activity: Biotech company; R&D; Biomaterials;
Syngenta Crop Protection A/S Finnish subsidiary PO Box 124, FI-10301 Karjaa, Finland Web site: www.syngenta.com Founded: 2001	Risto Knaapinen, Business manager Phone: + 358 19 236 106 Fax: + 358 19 236 108 risto.knaapinen at syngenta.com Arto Markkula, Crop Manager Phone: + 358 2 436 7151 Fax: + 358 2 436 7161 arto.markkula at syngenta.com	Production (and other) activities: Marketing Crop Protection products. R&D activities: Development in the field of crop protection and seeds. Categories of activity: Biotech support company; Supplier; Agro;
SYRINX Bioanalytics Oy		Categories of activity:
Systems Biology Worldwide Oy Mikonkatu 8, FI-00100 Helsinki Web site: www.systemsbiology.fi Founded: 2007	Juho Eväsoja, CEO Phone: +358 40 730 2313 Fax: +358 9 678 783 juho.evasoja at systemsbiology.fi Juha Saharinen, CTO Phone: +358 40 528 1973 Fax: +358 9 678 783 juha.saharinen at systemsbiology.fi	Production (and other) activities: We offer services in the area of: * Efficacy studies * In vitro ADMET * Safety studies * In vivo PK and bioanalytics * Discovery informatics Categories of activity: Biotech support company; R&D service; Drug discovery; Bioinformatics;
Tammer-Tutkan Maljat Oy		Categories of activity:
Technopolis Kuopio Oy		Categories of activity:
Technopolis Ventures Kuopio Oy		Categories of activity:
Technopolis Ventures Oulutech		Categories of activity:
Teriaka Ltd		Categories of activity:
Terivan Oy		Categories of activity:
Ternics Oy Riitankuja 7 A 11, FI-00840 Helsinki, Finland Web site: www.ternics.com Founded: 1993 Personnel: 1 (2005)	Erkki Tikkanen, CEO Phone: +358 9 6987 087 Fax: +358 9 6228 0332 tikkanen at ternics.inet.fi	Production (and other) activities: Management consulting, business and financing plans, numerical and investment analysis, acquisitions etc for health care and life science companies. Strategy studies and portfolio analysis for Public Actors and Life Science Centers and Venture Capital companies. Categories of activity: Biotech support company; Other service; Drug discovery; Diagnostics and devices; Biomaterials; Bioinformatics; Food and feed; Agro; Environment; Enzymes; Research reagents;
The A. I. Virtanen Institute for Molecular Sciences (AIVI)		Categories of activity:
Thermo Fisher Scientific Oy Ratastie 2, PO Box 100, FI-01621 Vantaa, Finland Web site: www.thermo.com Founded: 1971 Turnover: EUR 120 million (2008) Personnel: 560 (2008)	Timo Hildén, President Phone: +358 9 329 100 Fax: +358 9 3291 0500 timo.hilden at thermofisher.com	Production (and other) activities: Pipettes and consumables, Clinical Chemistry Analyzers and reagents, Clinical laboratory automation systems, Microplate instrumentation and magnetic particle instruments, Automated systems for analysis of water and environmental samples R&D activities: Liquid Handling, Detection instruments, Clinical chemistry analyzers and reagents, Automation. Core technologies: Liquid Handling, Detection instruments, Clinical chemistry analyzers and reagents, Automation. Categories of activity: Biotech company; Production; R&D; Diagnostics and devices; Environment;
Toxis Ltd Lemminkäisenkatu 14-18 C, 20520 TURKU Web site: www.sbw.fi; www.toxis.fi Founded: 2005 Turnover: EUR 0,5 million (2008) Personnel: 9 (2008)	Mari Madetoja, CEO Phone: +358 40 5190266 Fax: +358 2 236 0370 mari.madetoja at sbw.fi	Production (and other) activities: Toxis provides customizable services in in vivo disease models, safety pharmacology and toxicology, and pharmacokinetics. Toxis is a subsidiary of Systems Biology Worldwide (www.sbw.fi) corporation and therefore linked with a wide expertise in in silico bio- and chemoinformatics, ADME/DMPK analytics, preclinical GLP in vitro and in vivo toxicology, biostatistics and clinical data management, providing you a full service portfolio as well as a comprehensive portfolio of project solutions for drug discovery. Categories of activity: Biotech company; R&D service; Other service; Drug discovery; Biomaterials; Food and feed;
Triacle Biocomputing Kippolankuja 7, FIN-90540 Oulu, Finland Web site: www.triacle-bc.com Founded: 2001	Dr Andre H. Juffer, CEO Phone: +358 40 740 1486 Fax: +358 8 553 1141 andre.juffer at oulu.fi	Production (and other) activities: Production Customized software for life science companies. Core technologies: Protein modelling, biomolecular simulation technologies, protein analysis, enzymology, protein-membrane association. Categories of activity: Biotech company; R&D; Bioinformatics;
Turku Allergy Factory AB		Categories of activity:
Turku Biomaterials Centre		Categories of activity:
Turku Center for Disease Modeling		Categories of activity:
Turku CRC		Categories of activity:
Turku PET Centre		Categories of activity:
Turku Science Park Oy / BioTurku / HealthBIO Itäinen Pitkäkatu 4 B, FIN-20520 Turku, Finland Web site: www.turkusciencepark.com Founded: 1988 Turnover: EUR 7 million Personnel: 40	Tero Piispanen, Program Director Phone: +358 400 781 683 Fax: +358 2 4101 830 tero.piispanen at turkusciencepark.com	Production (and other) activities: Turku Science Park Ltd coordinates the activity of the regional BioTurku® cluster as well as the national HealthBIO network covering the five majour Finnish regional bioclusters within the new Centre of Expertise Programme 2007-2013. BioTurku® is the cluster of biotech actors in the Turku region including about 90 biotechnology companies, 2 universities as well as several educational and research institutes. Turku Science Park Ltd coordinates the development of the BioTurku® cluster, offers various services for the bio community and premises for national and international life science companies – with the goal to increase entrepreneurship in the Turku region.The focus areas of BioTurku are drug discovery, development and release, diagnostics and biomarker development. The three therapeutic focus areas are cancer and hormonal diseases, inflammatory and infectious diseases and diseases of the CNS. Regional strengths are preclinical and clinical research, bioimaging platform from cell to body and biomaterials. The HealthBIO work programme focuses on health-related biotechnology and associated business areas http://www.healthbio.fi Categories of activity: Biotech centre; Other service;
UCB Pharma Oy Finland		Categories of activity:
Uniq Bioresearch Oy Ltd Kuurinniityntie 26, FI-02750 Espoo, Finland Web site: www.uniqbioresearch.com Founded: 1996 Personnel: 2	Jouko Savolainen, Managing Directort Phone: +358 40 5102608 Fax: +358 9 5864503 jouko.savolainen at uniqbioresearch.com Antti Äkräs, Business Advisor Phone: +358 40 595 4621 Fax: +358 9 5864503 antti.akras at uniqbioresearch.com	Production (and other) activities: Production of modified/activated whey protein and whey protein fractions (ActiwheyR- proteins) for the products applications in food, health product, pharmaceutical and cosmetic industry. Production of the products containing ActiwheyR- proteins as an active ingredient in all the product area listed above. The main product category is the microencapsulation. R&D activities: Development of the method and process for the microencapsulation of the ingredients of customers e.g. omega-oils, other lipids, liposomes, plant extracts etc. Core technologies: Technology for the modification/activation and fractionation of whey protein; patented and for licensing. (Technology for the production of the ActiwheyR- proteins.) Technology for the microencapsulation of sensitive ingredients by using ActiwheyR- proteins as an encapsulant; patented and for licensing. Categories of activity: Biotech company; Production; R&D; R&D service; Biomaterials; Food and feed;
University of Kuopio Centre for Training and Development		Categories of activity:
University of Turku Clinical Research Services Turku CRST		Categories of activity:
Vaccine Research Center		Categories of activity:
Vactech Oy Biokatu 8, FI-33520 Tampere, Finland Web site: www.vactech.fi Founded: 2001 Personnel: 8 (2009)	Raimo Harju, CEO Phone: +358-3-4478111 Fax: forname.surname (at) vactech.fi Olli Laitinen, CSO Phone: +358-3-4478111 Fax: forname.surname (at) vactech.fi	Production (and other) activities: We develop and license vaccines and novel technologies for vaccines and diagnostics. R&D activities: Primary lead: • Preventive vaccine for Type 1 Diabetes Other leads: • Asthma-Allergy vaccine • IMAVAC™ -technology based on VLP (Virus Like Particles) • Immunomodulators IPR: • Type 1 Diabetes: internationally patented • Asthma and Allergy: PCT passed • Celiac: PCT passed Deals: • Diabetes vaccine licensed to Sanofi -Pasteur Core technologies: Traditional vaccines contain either killed or attenuated viruses. A more modern approach is a concept of Virus Like Particles, VLP. VLP-based vaccines have important advantages over traditional vaccines since they give stronger immunostimulation than denatured virus particles or soluble viral proteins. In addition, they are often eff ective at eliciting both T-and B-cell immune responses while traditional vaccines induce mainly B-cell responses. _ e potential of this technology is already demonstrated by the striking success of the fi rst VLP-based human vaccines targeting papillomavirus- induced cervical cancer. In addition to vaccines Vactech IMAVAC™ VLP technology opens doors to other applications such as vaccine components (adjuvant), delivery vehicles and diagnostics. Categories of activity: Biotech company; R&D; R&D service; Drug discovery; Diagnostics and devices;
Valio Ltd PO Box 10, FI-00039 Valio, Finland Web site: www.valio.com Founded: 1905 Turnover: EUR 1582 million (2004) Personnel: 4389 (2004)	Dr Tiina Mattila-Sandholm, Senior Vice President, R&D Phone: +358 10 381 3004 Fax: +358 10 381 3009 tiina.mattila-sandholm at valio.fi	Production (and other) activities: Milk production, collection, manaufacture, marketing and product development of the dairy products of Valio. Marketing of probiotic bacteria, starter cultures, animal probiotics and antibiotic tests. R&D activities: Production development of the dairy products of Valio. Nutrition research to test the probiotic bacteria and milk components used in functional foods, lactic acid bacteria. Core technologies: Low lactose products, lactose free milk, milk membrane process technology, enzyme technology, fermentation process technology. Categories of activity: Biotech company; Production; R&D; Food and feed;
Verdera Oy PO Box 5 (Kurjenkellontie 5 B), FI-02271 Espoo, Finland Web site: www.verdera.fi Founded: 2002 Personnel: 13 (2007)	Nils-Johan Grönholm, Managing Director Phone: +358 10 217 3730 Fax: +358 10 217 3711 njgronholm at lallemand.com Heli Hynynen, Assistant Phone: +358 10 217 3720 Fax: +358 10 217 3711 hhynynen at lallemand.com	Production (and other) activities: Developes, produces and markets biological pesticides and growth promoters used in forestry, horticulture, turf and amenity. R&D activities: Control of soil-borne as well as foliar plant diseases, process development of the production of biofungicides. Core technologies: Control of plant diseases by microorganisms, formulation techniques for microorganism. Categories of activity: Biotech company; Production; R&D; Agro;
Verman Oy		Categories of activity:
Verso Finland Oy		Categories of activity:
Vetcare Ltd Vetcare Ltd, PO Box 99, FIN-24101 Salo, Finland Web site: www.vetcare.fi Founded: 1992 Turnover: EUR 3 million Personnel: 12	Jukka Kuussaari, Managing Director Phone: +358 2 72 72 72 Fax: +358 2 72 72 70 jukka.kuussaari at vetcare.fi	Production (and other) activities: Research and development, regulatory services and marketing of veterinary pharmaceuticals. R&D activities: R&D of veterinary pharmaceuticals and other animal health related products. Categories of activity: Biotech company; R&D; Drug discovery;
Viikki Food Centre		Categories of activity:
Visipoint Oy		Categories of activity:
Vitabalans Oy		Categories of activity:
Vivoxid Ltd Biolinja 12, FI-20750 Turku, Finland Web site: www.vivoxid.com Founded: 2001 Personnel: 20 (2007)	Tomi Numminen, President, CEO Phone: +358 (0)20 7622 266 Fax: +358 (0)20 7622 262 contact(a)vivoxid.com	Production (and other) activities: Development, production and marketing of biomaterial, medical device products. Quality system according to ISO 9001:2000 and ISO 13485:2003. R&D activities: Vivoxid’s active research program aims to create a continuous flow of new inventions and product ideas to its development portfolio. Vivoxid’s core knowhow relateds to the development of biomaterials and their interactions with the various tissues. Research projects utilize the core competence in many application areas such as medical device development, regenerative medicine, in vitro analytics etc. These projects provide the basic proof of concept, a well educated expert group behind the technology and gives the tools for the actual product development that are all prerequisites for any successful project. Vivoxid Ltd has its roots in strong university research. The Turku University Biomaterials Research Project and Åbo Akademi Biomaterials research were established in 1986 and now involve altogether around 100 active research personnel. The research interests and main competence areas in Turku University, Åbo Akademi University have evolved around Silica titanium oxides, glasses, sol-gel materials, biodegradable polymers and their composites as well as their application in many areas of medicine and biological research. Core technologies: BonAliveTM is already registered and sold in Europe and is under registration phase in several other countries, MetAliveTM is in its clinical phase and is expected to enter the market with first indications in 2008 and FiberLiveTM is in the research and development phase with market entrance expected in 2012. Various other technology developments are at an even earlier research and development phase. Categories of activity: Biotech company; Biotech support company; Production; R&D; Other service; Supplier; Diagnostics and devices; Biomaterials;
VTT Technical Research Centre of Finland (Biotechnology food industry pharmaceuticals)		Categories of activity:
VWR International Pihatörmä 1 C 1, 02240 Espoo, Finland Web site: http://fi.vwr.com Founded: 1985 Turnover: EUR 11,5 million (2008) Personnel: 27 (2008)	Minna Nymark, Managing Director Phone: +358 44 092 4030 Fax: minna.nymark at fi.vwr.com Kaarlo Nuutinen, Sales Director Phone: +358 40 0310 439 Fax: kaarlo.nuutinen at fi.vwr.com	Production (and other) activities: VWR International is a global laboratory supply and distribution company with worldwide sales in excess of $3.7 billion. VWR enables the advancement of the world’s most critical research through the distribution of a highly diversified product line to most of the world’s top pharmaceutical and biotech companies, as well as industrial, educational and governmental organizations. With 150 years of industry experience, VWR offers a well-established distribution network that reaches thousands of specialized labs and facilities spanning the globe. VWR has over 6,500 associates around the world working to streamline the way researchers across North America, Europe, and Asia stock and maintain their labs. In addition, VWR further supports its customers by providing onsite services, storeroom management, product procurement, supply chain systems integration and technical services. R&D activities: - Core technologies: - Categories of activity: Biotech support company; Production; Other service; Supplier; Drug discovery; Diagnostics and devices; Biomaterials; Food and feed; Environment; Enzymes; Research reagents;
Xemet Ltd Myötätuulenmäki 1 B 34, 02330 Espoo Web site: www.xemet.com	Tomi Heiskanen, CEO Phone: +358 400 491568 Fax: +358 9 4129090 tomi at xemet.com	Production (and other) activities: Mathematical modeling and simulation services and software for biological applications R&D activities: Mathematical and numerical methods for simulation Core technologies: Computer simulation Categories of activity: Biotech company; Biotech support company; R&D service; Drug discovery; Bioinformatics; Environment;
Zeus Tech Oy		Categories of activity:
Zora Biosciences Oy FI-02150 Espoo Web site: www.zora.fi Founded: 2006	Reini Hurme, Chief Executive Officer Phone: +358 40 576 0766 Fax: reini.hurme(at)zora.fi	Production (and other) activities: Zora Biosciences Oy is a biotechnology company focusing on lipidomics. Zora provides analytical services to pharmaceutical and biotechnology companies. Zora services have been applied to pharmaceutical research and development efforts in compound selection, toxicity studies, efficacy and safety assessment among many. R&D activities: Zora’s own research activities are geared toward biomarker and drug target identification. Zora biomarker and drug target research covers several therapy areas and promising biomarker candidates are being investigated in cardiovascular diseases, diabetes and CNS disorders. Core technologies: Lipidomics, lipid biochemistry, mass spectrometry, bioinformatics Categories of activity: Biotech company; R&D; R&D service; Drug discovery; Diagnostics and devices; Bioinformatics;